TSSK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A6NDS4 | T152 | Sugiyama | TBC1D3B TBC1D3I | KEKGKRSSEHIQRIDRDISGtLRKHMFFRDRYGTKQRELLH |
| A6NKT7 | S980 | Sugiyama | RGPD3 RGP3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| B9A6J9 | T152 | Sugiyama | TBC1D3L PRC17 | KEKGKRSSEHIQRIDRDVSGtLRKHIFFRDRYGTKQRELLH |
| O00151 | S84 | Sugiyama | PDLIM1 CLIM1 CLP36 | LEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKM |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00273 | S302 | Sugiyama | DFFA DFF1 DFF45 H13 | TETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDLQN |
| O00273 | S37 | Sugiyama | DFFA DFF1 DFF45 H13 | TLKPCLLRRNysREQHGVAAsCLEDLRSKACDILAIDKSLT |
| O14715 | S979 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15067 | S225 | Sugiyama | PFAS KIAA0361 | KRFQELQRNPstVEAFDLAQsNsEHSRHWFFKGQLHVDGQK |
| O15226 | T620 | Sugiyama | NKRF ITBA4 NRF | KIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQIA |
| O43464 | S435 | Sugiyama | HTRA2 OMI PRSS25 | AIGEQMVQNAEDVYEAVRTQsQLAVQIRRGRETLTLYVTPE |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60447 | S689 | Sugiyama | EVI5 NB4S | AELEIQKEEGKLQGQLNKsDsNQYIGELKDQIAELNHELRC |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75122 | S313 | Sugiyama | CLASP2 KIAA0627 | YNSLEPSYQKSLQTYLKssGsVAsLPQsDRsssssQEsLNR |
| O75128 | S1171 | Sugiyama | COBL KIAA0633 | SALLAAIRGHSGTCSLRKVAsSAsEELQSFRDAALSAQGSE |
| O95155 | S79 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | NMtPAtsPIGASGVAHRsQssEGVssLsssPsNsLEtQsQs |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95297 | S260 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | IyAQLDHsGGHHSDKINKSEsVVyADIRKN___________ |
| O95425 | S228 | Sugiyama | SVIL | GQELsATRQAHDLsPAAEsssTFsFSGRDssFtEVPRsPKH |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06744 | S22 | Sugiyama | GPI | AALTRDPQFQKLQQWyREHRsELNLRRLFDANKDRFNHFSL |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | S58 | Sugiyama | PFN1 | KtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsL |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08670 | S438 | Sugiyama | VIM | FssLNLREtNLDsLPLVDtHsKRTLLIKtVEtRDGQVINEt |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DJD0 | S964 | Sugiyama | RGPD1 RANBP2L6 RGP1 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S410 | Sugiyama | HSPD1 HSP60 | LNERLAKLsDGVAVLKVGGtsDVEVNEKKDRVtDALNAtRA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12956 | S560 | Sugiyama | XRCC6 G22P1 | VtKRKHDNEGSGSKRPKVEysEEELKTHISKGTLGKFTVPM |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14868 | S192 | Sugiyama | DARS1 DARS PIG40 | ATVNQDTRLDNRVIDLRTsTsQAVFRLQSGICHLFRETLIN |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16949 | S28 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | VKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDLsLE |
| P16949 | S38 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20933 | S59 | Sugiyama | AGA | ATEAAWRALAsGGSALDAVEsGCAMCEREQCDGSVGFGGSP |
| P21108 | S11 | Sugiyama | PRPS1L1 PRPS3 PRPSL | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P21333 | S1029 | Sugiyama | FLNA FLN FLN1 | VGPSGAAVPCKVEPGLGADNsVVRFLPREEGPYEVEVTYDG |
| P21333 | S481 | Sugiyama | FLNA FLN FLN1 | AGVPIPRsPyTVtVGQACNPsACRAVGRGLQPKGVRVKETA |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22059 | S386 | Sugiyama | OSBP OSBP1 | ITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEKR |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | T465 | Sugiyama | MSN | WQQKAQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDE |
| P26373 | S106 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | IHKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLIL |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29966 | S29 | Sugiyama | MARCKS MACS PRKCSL | AAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsPAA |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P30622 | S197 | Sugiyama | CLIP1 CYLN1 RSN | KEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIGDR |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P31949 | S35 | Sugiyama | S100A11 MLN70 S100C | ESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKNQK |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40925 | S153 | Sugiyama | MDH1 MDHA | ANtNCLtAsKSAPSIPKENFsCLtRLDHNRAKAQIALKLGV |
| P42566 | S748 | Sugiyama | EPS15 AF1P | STLSKVNNEDPFRSATSssVsNVVITKNVFEETSVKSEDEP |
| P42766 | S29 | Sugiyama | RPL35 | LRGKKKEELLKQLDDLKVELsQLRVAKVTGGAASKLsKIRV |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | S458 | Sugiyama | CCT3 CCTG TRIC5 | RAVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtW |
| P49792 | S1955 | Sugiyama | RANBP2 NUP358 | GVIFGQTSSTFTFADLAKstsGEGFQFGKKDPNFKGFSGAG |
| P50395 | S270 | Sugiyama | GDI2 RABGDIB | MLNKPIEEIIVQNGKVIGVKsEGEIARCKQLICDPSyVKDR |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50851 | S1237 | Sugiyama | LRBA BGL CDC4L LBA | NLTRETKLINDCHGsVSEAssEQKIAKLDVsNVAtDtERLE |
| P50990 | S162 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAKL |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52943 | S114 | Sugiyama | CRIP2 CRP2 | PAARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVY |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S17 | Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P54105 | S198 | Sugiyama | CLNS1A CLCI ICLN | TAEGQATLERLEGMLsQsVssQYNMAGVRtEDsIRDyEDGM |
| P54105 | S42 | Sugiyama | CLNS1A CLCI ICLN | DTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEYPTIS |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55011 | S77 | Sugiyama | SLC12A2 NKCC1 | RDEGPAAAGDGLGRPLGPtPsQsRFQVDLVSENAGRAAAAA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60891 | S11 | Sugiyama | PRPS1 | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63241 | S75 | Sugiyama | EIF5A | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P82094 | S199 | Sugiyama | TMF1 ARA160 | ETVNKESDMKVPTVSLKVsEsVIDVKTTMESISNTstQsLT |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q00587 | S350 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | HyPEMDARQERVEVLPQARAsWEsLDEEWRAPQAGsRtPVP |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q00688 | T98 | Sugiyama | FKBP3 FKBP25 | ISKVSEQVKNVKLNEDKPKEtKsEEtLDEGPPKYTKSVLKK |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S2184 | Sugiyama | SPTBN1 SPTB2 | ssPIPsPtsDRKAKTALPAQsAAtLPARtQEtPsAQMEGFL |
| Q01105 | S63 | Sugiyama | SET | EAIEHIDEVQNEIDRLNEQAsEEILKVEQKYNKLRQPFFQK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01581 | S404 | Sugiyama | HMGCS1 HMGCS | YSLKVTQDATPGSALDKITAsLCDLKSRLDSRTGVAPDVFA |
| Q01970 | S1041 | Sugiyama | PLCB3 | TKEGEDEAKRYQEFQNRQVQsLLELREAQVDAEAQRRLEHL |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q06210 | T262 | Sugiyama | GFPT1 GFAT GFPT | sQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDAS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13136 | S338 | Sugiyama | PPFIA1 LIP1 | MEERITTLEKRYLAAQREATsVHDLNDKLENEIANKDSMHR |
| Q13136 | S668 | Sugiyama | PPFIA1 LIP1 | EEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPAss |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13428 | S1230 | Sugiyama | TCOF1 | GLTPANSQASKAtPKLDssPsVsstLAAKDDPDGKQEAKPQ |
| Q13573 | S182 | Sugiyama | SNW1 SKIIP SKIP | AMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEM |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14203 | S31 | Sugiyama | DCTN1 | RTPSGSRMsAEASARPLRVGsRVEVIGKGHRGTVAYVGATL |
| Q14247 | S345 | Sugiyama | CTTN EMS1 | EDVtQVssAyQKTVPVEAVtsKtsNIRANFENLAKEKEQED |
| Q14247 | S348 | Sugiyama | CTTN EMS1 | tQVssAyQKTVPVEAVtsKtsNIRANFENLAKEKEQEDRRK |
| Q14432 | S543 | Sugiyama | PDE3A | ssPCssPLQGtPASSLVSKIsAVQFPEsADTTAKQSLGSHR |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14684 | S392 | Sugiyama | RRP1B KIAA0179 | EKTNLEKEKGSRVFCVEEEDsEssLQKRRRKKKKKHHLQPE |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14C86 | S902 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | AEMEAFKQRHSYPERLVRsRssDIVSSVRRPMSDPSWNRRP |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15121 | S116 | Sugiyama | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15276 | S407 | Sugiyama | RABEP1 RAB5EP RABPT5 RABPT5A | GDPFSKSDNDMFKDGLRRAQstDsLGtsGsLQSKALGYNYK |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15398 | S789 | Sugiyama | DLGAP5 DLG7 KIAA0008 | EKNTAsQNsILEEGEtKIsQsELFDNKsLttECHLLDsPGL |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15751 | S1512 | Sugiyama | HERC1 | LtAESRLVHtsPNYRLIKsRsEsDLsQPEsDEEGYALsGRR |
| Q15751 | S1514 | Sugiyama | HERC1 | AESRLVHtsPNYRLIKsRsEsDLsQPEsDEEGYALsGRRNV |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q27J81 | S1194 | Sugiyama | INF2 C14orf151 C14orf173 | EDEEDtAPEsALDtsLDKsFsEDAVtDssGsGtLPRARGRA |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5JSH3 | S565 | Sugiyama | WDR44 RPH11 | DYFNNMRMKYNtEGRVsPsPsQEsLsssKsDTDtGVCsGtD |
| Q5SW79 | S865 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | sPNIPIELIPHINKQTsstPssLALtsAsRIRERsEsLDPD |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5T5U3 | S1553 | Sugiyama | ARHGAP21 ARHGAP10 KIAA1424 | AQKSSHLEETGSDSGTLLSTsSQASLARFSMKKSTSPETKH |
| Q5T5Y3 | S1398 | Sugiyama | CAMSAP1 | sCSDsGTKCSSTPDNLSRtQsGssLsLAsAAttEPESVHSG |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q5VT52 | S1177 | Sugiyama | RPRD2 KIAA0460 HSPC099 | GGLTGFKTAPYKERAPQFQEsVGsFRsNsFNstFEHHLPPs |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DHY5 | T152 | Sugiyama | TBC1D3G | KEKGKRSSEHIQRIDRDISGtLRKHMFFRDRYGTKQRELLH |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6IPX1 | T152 | Sugiyama | TBC1D3C TBC1D3D | KEKGKRSSEHIQRIDRDVSGtLRKHIFFRDRYGTKQRELLH |
| Q6IS14 | S75 | Sugiyama | EIF5AL1 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PID6 | S19 | Sugiyama | TTC33 | __MASFGWKRKIGEKVSKVTsQQFEAEAADEKDVVDNDEGN |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z3J3 | S980 | Sugiyama | RGPD4 RGP4 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| Q7Z3T8 | S362 | Sugiyama | ZFYVE16 KIAA0305 | AQEDsKsLDLKDNDVIQDsSsALHVSSKDVPSSLSCLPASG |
| Q7Z460 | S545 | Sugiyama | CLASP1 KIAA0622 MAST1 | yHTLESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNR |
| Q7Z6B0 | S139 | Sugiyama | CCDC91 GGABP HSD8 | VDDSEDPGANVSNIQLQQKIsSLEIKLKVSEEEKQRIKQDV |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86X02 | S318 | Sugiyama | CDR2L HUMPPA | AQDGVssPAAsPGHVVRKsCsDTALNAIVAKDPASRHAGNL |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWZ3 | S122 | Sugiyama | ANKHD1 KIAA1085 MASK VBARP PP2500 | EVEsFILDQEDLDNPVLKTTsEIFLSSTAEGADLRTVDPET |
| Q8IYB3 | S240 | Sugiyama | SRRM1 SRM160 | tPELPEPsVKVKEPsVQEAtstsDILKVPKPEPIPEPKEPs |
| Q8IYB3 | T239 | Sugiyama | SRRM1 SRM160 | KtPELPEPsVKVKEPsVQEAtstsDILKVPKPEPIPEPKEP |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N6T3 | S345 | Sugiyama | ARFGAP1 ARF1GAP | DQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWE |
| Q8N806 | S265 | Sugiyama | UBR7 C14orf130 | KDDVREVKVEQNsEPCAGsssEsDLQtVFKNESLNAESKSG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBK3 | S357 | Sugiyama | SUMF1 PSEC0152 UNQ3037/PRO9852 | HRSYCYRYRCAARSQNTPDSsAsNLGFRCAADRLPtMD___ |
| Q8NBK3 | S359 | Sugiyama | SUMF1 PSEC0152 UNQ3037/PRO9852 | SYCYRYRCAARSQNTPDSsAsNLGFRCAADRLPtMD_____ |
| Q8NEZ2 | S326 | Sugiyama | VPS37A HCRP1 | QMKSTFEKKMQRQHELSEsCsASALQARLKVAAHEAEEESD |
| Q8TDD1 | S624 | Sugiyama | DDX54 | FQQGQQGRQEQQEGPVGPAPsRPALQEKQPEKEEEEEAGEs |
| Q8WWI1 | S1510 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WWI1 | S704 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KKRLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEM |
| Q8WWI1 | S709 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQKIKS |
| Q8WWI1 | T1425 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KTEEAsSGFLPGDRNKsRsttELDDYSTNKNGNNKYLDQIG |
| Q8WXE0 | S1154 | Sugiyama | CASKIN2 KIAA1139 | EsTGTVGPGQAQQRLEQTSSsLAAALRAAEKSIGTKEQEGT |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q92609 | S541 | Sugiyama | TBC1D5 KIAA0210 | EsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssAtK |
| Q92620 | S438 | Sugiyama | DHX38 DDX38 KIAA0224 PRP16 | DGRIVFTKQPEPVIPVKDATsDLAIIARKGSQTVRKHREQK |
| Q96D15 | S119 | Sugiyama | RCN3 UNQ239/PRO272 | LAELRAWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEELR |
| Q96D15 | S76 | Sugiyama | RCN3 UNQ239/PRO272 | HEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGDGDGW |
| Q96EK9 | T157 | Sugiyama | KTI12 SBBI81 | RAEEDGRAQAAGSSVLRELHtADSVVNGSAQADVPKELERE |
| Q96HE7 | S145 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | NNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNF |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96IZ0 | Y226 | Sugiyama | PAWR PAR4 | LLDPGSsyLLQEPPRTVSGRyKsttsVsEEDVsSRYsRTDR |
| Q96PF2 | S153 | Sugiyama | TSSK2 DGSG SPOGA2 STK22B | VHRDLKCENLLLDKDFNIKLsDFGFSKRCLRDSNGRIILSK |
| Q96PF2 | S258 | Sugiyama | TSSK2 DGSG SPOGA2 STK22B | SKNLTCECKDLIYRMLQPDVsQRLHIDEILSHSWLQPPKPK |
| Q96PF2 | Y126 | Sugiyama | TSSK2 DGSG SPOGA2 STK22B | GALHEDVARKMFRQLSSAVKyCHDLDIVHRDLKCENLLLDK |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99614 | S187 | Sugiyama | TTC1 TPR1 | KQDKKEMAINDCSKAIQLNPsyIRAILRRAELYEKTDKLDE |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q99666 | S979 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| Q99700 | T529 | Sugiyama | ATXN2 ATX2 SCA2 TNRC13 | GRQNsPRMGQPGsGSMPSRstsHtsDFNPNSGSDQRVVNGG |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BRS2 | S130 | Sugiyama | RIOK1 RIO1 | DKVLRKFENKINLDKLNVtDsVINKVTEKSRQKEADMYRIK |
| Q9BVS4 | S412 | Sugiyama | RIOK2 RIO2 | EMTEFNQALEEIKGQVVENNsVTEFsEEKNRTENYNRQDGQ |
| Q9BXS6 | S365 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | EAtQtPVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQSKE |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9GZV4 | S75 | Sugiyama | EIF5A2 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDYQLICIQ |
| Q9H2G2 | S518 | Sugiyama | SLK KIAA0204 STK2 | tVDLVSQEtGEKEANIQAVDsEVGLTKEDtQEKLGEDDKTQ |
| Q9H3Q1 | S315 | Sugiyama | CDC42EP4 BORG4 CEP4 | sARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRARAAV |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H788 | S118 | Sugiyama | SH2D4A PPP1R38 SH2A | IAERARLKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPD |
| Q9H7E2 | S367 | Sugiyama | TDRD3 | LEGSGLPRNRGsERPSTssVsEVWAEDRIKCDRPYSRYDRT |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9HD42 | S101 | Sugiyama | CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1 | TMKGVTKNMAQVTKALDKALsTMDLQKVSSVMDRFEQQVQN |
| Q9NP61 | S429 | Sugiyama | ARFGAP3 ARFGAP1 | EPVENTDEAQKKFGNVKAIssDMyFGRQsQADYETRARLER |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NY61 | S61 | Sugiyama | AATF CHE1 DED HSPC277 | DEGEDGEGDFLVVGsIRKLAsAsLLDtDKRYCGKTTSRKAW |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9UGP4 | T265 | Sugiyama | LIMD1 | GGQNSGIGGRssEKPtGLWstASSQRVsPGLPsPNLENGAP |
| Q9UHX1 | S461 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | sIsGssARHMVMQKLLRKQEsTVMVLRNMVDPKDIDDDLEG |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UKV3 | T563 | Sugiyama | ACIN1 ACINUS KIAA0670 | TEECLKQPsLEQKEGRRAsHtLLPSHRLKQSADSSSSRSSS |
| Q9ULT8 | S1395 | Sugiyama | HECTD1 KIAA1131 | AAGSSsRKGssssVCsVASSsDISLGSTKTERRSEIVMEHS |
| Q9UNF1 | S85 | Sugiyama | MAGED2 BCG1 | KAtEVsKtPEAREAPAtQAssttQLtDtQVLAAENKSLAAD |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2280 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtAPAVNLAGA |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | S74 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | GsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGE |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y4K4 | S335 | Sugiyama | MAP4K5 | AIIRHTIRSTNRNARAERtAsEINFDKLQFEPPLRKETEAR |
| Q9Y4X5 | S514 | Sugiyama | ARIH1 ARI MOP6 UBCH7BP HUSSY-27 | NQADLENATEVLSGYLERDIsQDsLQDIKQKVQDKYRYCES |
| Q9Y6Y8 | S894 | Sugiyama | SEC23IP MSTP053 | FISSLKSAWQTLNEFARAHtsstQLQEELEKVANQIKEEEE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.566558e-11 | 10.448 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.427525e-09 | 8.845 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.194554e-08 | 7.377 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.191741e-08 | 7.208 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.304709e-07 | 6.884 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.169508e-07 | 6.664 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.877560e-07 | 6.005 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.034375e-06 | 5.985 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.391022e-06 | 5.621 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.654163e-06 | 5.437 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.348309e-06 | 5.272 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.768355e-06 | 5.239 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.436669e-06 | 5.129 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.960240e-06 | 5.157 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.245103e-06 | 5.140 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.247597e-06 | 5.034 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.182390e-05 | 4.927 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.388700e-05 | 4.857 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.388700e-05 | 4.857 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.352415e-05 | 4.869 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.451911e-05 | 4.838 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.609809e-05 | 4.793 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.131557e-05 | 4.671 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.131557e-05 | 4.671 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.432694e-05 | 4.614 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.970840e-05 | 4.527 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.091824e-05 | 4.510 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.091824e-05 | 4.510 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.364333e-05 | 4.196 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.850743e-05 | 4.164 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.679645e-05 | 4.115 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.227653e-05 | 4.085 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.655465e-05 | 4.063 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.170327e-05 | 4.038 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.020072e-04 | 3.991 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.020072e-04 | 3.991 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.645134e-04 | 3.784 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.733147e-04 | 3.761 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.441989e-04 | 3.612 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.541751e-04 | 3.595 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.676187e-04 | 3.572 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.708562e-04 | 3.567 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.860021e-04 | 3.544 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.181104e-04 | 3.497 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.471796e-04 | 3.459 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.100555e-04 | 3.387 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.281945e-04 | 3.368 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.458254e-04 | 3.351 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.466542e-04 | 3.350 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.727854e-04 | 3.325 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.804116e-04 | 3.318 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.076862e-04 | 3.216 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.848923e-04 | 3.164 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.650426e-04 | 3.177 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.866527e-04 | 3.163 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.248639e-04 | 3.140 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.391278e-04 | 3.131 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.470339e-04 | 3.072 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.053326e-03 | 2.977 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.416677e-03 | 2.849 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.380984e-03 | 2.860 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.406948e-03 | 2.852 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.416677e-03 | 2.849 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.435015e-03 | 2.843 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.475006e-03 | 2.831 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.884921e-03 | 2.725 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.033930e-03 | 2.692 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.145366e-03 | 2.668 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.169659e-03 | 2.664 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.679127e-03 | 2.572 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.734082e-03 | 2.563 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.734082e-03 | 2.563 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.496440e-03 | 2.603 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.496440e-03 | 2.603 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.496440e-03 | 2.603 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.728277e-03 | 2.564 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.496440e-03 | 2.603 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.717475e-03 | 2.566 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.871852e-03 | 2.542 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.920569e-03 | 2.535 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.033087e-03 | 2.518 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.123321e-03 | 2.505 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.588562e-03 | 2.445 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.409928e-03 | 2.467 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.625831e-03 | 2.441 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.715244e-03 | 2.430 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.961173e-03 | 2.402 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.950919e-03 | 2.403 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.900839e-03 | 2.409 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.975018e-03 | 2.401 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.011311e-03 | 2.397 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.011311e-03 | 2.397 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.011311e-03 | 2.397 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.011311e-03 | 2.397 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.011311e-03 | 2.397 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.677479e-03 | 2.330 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.677479e-03 | 2.330 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.965685e-03 | 2.304 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.002591e-03 | 2.301 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.064965e-03 | 2.295 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.800569e-03 | 2.319 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.042494e-03 | 2.219 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.063272e-03 | 2.217 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.003344e-03 | 2.222 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.073516e-03 | 2.217 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.272217e-03 | 2.203 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.397663e-03 | 2.194 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.895593e-03 | 2.161 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.895593e-03 | 2.161 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.895593e-03 | 2.161 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.895593e-03 | 2.161 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.524351e-03 | 2.185 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.524351e-03 | 2.185 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.524351e-03 | 2.185 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.524351e-03 | 2.185 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.524351e-03 | 2.185 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.577600e-03 | 2.182 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.673297e-03 | 2.176 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.529030e-03 | 2.185 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.060377e-03 | 2.151 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.952597e-03 | 2.099 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.536110e-03 | 2.123 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.900840e-03 | 2.102 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.900840e-03 | 2.102 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.864502e-03 | 2.104 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.864502e-03 | 2.104 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.054276e-03 | 2.094 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.199782e-03 | 2.086 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.556193e-03 | 2.068 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.792602e-03 | 2.056 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.205488e-03 | 2.036 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.821848e-03 | 2.008 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 9.811895e-03 | 2.008 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.066501e-02 | 1.972 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.075632e-02 | 1.968 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.075632e-02 | 1.968 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.075632e-02 | 1.968 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.194860e-02 | 1.923 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.201486e-02 | 1.920 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.115121e-02 | 1.953 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.115906e-02 | 1.952 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.194860e-02 | 1.923 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.201486e-02 | 1.920 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.224833e-02 | 1.912 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.248474e-02 | 1.904 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.252235e-02 | 1.902 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.282960e-02 | 1.892 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.340163e-02 | 1.873 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.348458e-02 | 1.870 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.352789e-02 | 1.869 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.353843e-02 | 1.868 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.493385e-02 | 1.826 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.493385e-02 | 1.826 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.493385e-02 | 1.826 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.398553e-02 | 1.854 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.409319e-02 | 1.851 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.400408e-02 | 1.854 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.454039e-02 | 1.837 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.543954e-02 | 1.811 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.617737e-02 | 1.791 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.713206e-02 | 1.766 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.720683e-02 | 1.764 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.749941e-02 | 1.757 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.801447e-02 | 1.744 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.818298e-02 | 1.740 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.818298e-02 | 1.740 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.826070e-02 | 1.738 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.847796e-02 | 1.733 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.921422e-02 | 1.716 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.953225e-02 | 1.709 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.092727e-02 | 1.679 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.062909e-02 | 1.686 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.087400e-02 | 1.680 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.054101e-02 | 1.687 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.190071e-02 | 1.660 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.226839e-02 | 1.652 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.231082e-02 | 1.651 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.292959e-02 | 1.640 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.292959e-02 | 1.640 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.292959e-02 | 1.640 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.506894e-02 | 1.601 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.506894e-02 | 1.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.506894e-02 | 1.601 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.506894e-02 | 1.601 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.455720e-02 | 1.610 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.716544e-02 | 1.566 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.505442e-02 | 1.601 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.505442e-02 | 1.601 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.455720e-02 | 1.610 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.716544e-02 | 1.566 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.733442e-02 | 1.563 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.804908e-02 | 1.552 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.979780e-02 | 1.526 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.061563e-02 | 1.514 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.116974e-02 | 1.506 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.116974e-02 | 1.506 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.155401e-02 | 1.501 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.384659e-02 | 1.470 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.509455e-02 | 1.455 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.587584e-02 | 1.445 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.721306e-02 | 1.429 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.072901e-02 | 1.390 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.856895e-02 | 1.414 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.856895e-02 | 1.414 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.234993e-02 | 1.373 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.050322e-02 | 1.393 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.912468e-02 | 1.408 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.054569e-02 | 1.392 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.093381e-02 | 1.388 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.847292e-02 | 1.415 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.856895e-02 | 1.414 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.787972e-02 | 1.422 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.018710e-02 | 1.396 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.751191e-02 | 1.426 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.751191e-02 | 1.426 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.751191e-02 | 1.426 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.829049e-02 | 1.417 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.006519e-02 | 1.397 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.934333e-02 | 1.405 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.234993e-02 | 1.373 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.334188e-02 | 1.363 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.374179e-02 | 1.359 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.374179e-02 | 1.359 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.374179e-02 | 1.359 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.410187e-02 | 1.356 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.410187e-02 | 1.356 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.410187e-02 | 1.356 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.458112e-02 | 1.351 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.518301e-02 | 1.345 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.691128e-02 | 1.329 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.899384e-02 | 1.310 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.993438e-02 | 1.302 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.993438e-02 | 1.302 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.140059e-02 | 1.289 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.140059e-02 | 1.289 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.140065e-02 | 1.289 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.173411e-02 | 1.286 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.197338e-02 | 1.284 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.224586e-02 | 1.282 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.298963e-02 | 1.276 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.394485e-02 | 1.194 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.856946e-02 | 1.232 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.856946e-02 | 1.232 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.747076e-02 | 1.241 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.538566e-02 | 1.257 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.401898e-02 | 1.194 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.182767e-02 | 1.209 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.938258e-02 | 1.226 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.875123e-02 | 1.231 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.215296e-02 | 1.207 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.943348e-02 | 1.226 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.943348e-02 | 1.226 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.770932e-02 | 1.239 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.825090e-02 | 1.235 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.507292e-02 | 1.187 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.507292e-02 | 1.187 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.507292e-02 | 1.187 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.609885e-02 | 1.180 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.966060e-02 | 1.099 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 7.966060e-02 | 1.099 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 7.966060e-02 | 1.099 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.185400e-02 | 1.144 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.902766e-02 | 1.161 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.813215e-02 | 1.107 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.813215e-02 | 1.107 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.004936e-02 | 1.155 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.004936e-02 | 1.155 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.356607e-02 | 1.133 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.537307e-02 | 1.123 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.639449e-02 | 1.178 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.864408e-02 | 1.104 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.003520e-02 | 1.155 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.685589e-02 | 1.175 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.375820e-02 | 1.132 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.747933e-02 | 1.171 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.004936e-02 | 1.155 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.586377e-02 | 1.120 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.339902e-02 | 1.134 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.185400e-02 | 1.144 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.586377e-02 | 1.120 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.586377e-02 | 1.120 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.890373e-02 | 1.162 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.772770e-02 | 1.169 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.402813e-02 | 1.131 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.890373e-02 | 1.162 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.639359e-02 | 1.117 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.103923e-02 | 1.149 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.266755e-02 | 1.139 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.855688e-02 | 1.105 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.122130e-02 | 1.147 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.514459e-02 | 1.124 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.402813e-02 | 1.131 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 7.185400e-02 | 1.144 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.601991e-02 | 1.119 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.876183e-02 | 1.104 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.004936e-02 | 1.155 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.970132e-02 | 1.157 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.994490e-02 | 1.097 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.994490e-02 | 1.097 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.128220e-02 | 1.090 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.316960e-02 | 1.080 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.316960e-02 | 1.080 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.393344e-02 | 1.076 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.424241e-02 | 1.074 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.424241e-02 | 1.074 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.509114e-02 | 1.070 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.545128e-02 | 1.068 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.569952e-02 | 1.067 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.638952e-02 | 1.064 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.647001e-02 | 1.063 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.647001e-02 | 1.063 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.647001e-02 | 1.063 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.647001e-02 | 1.063 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.647001e-02 | 1.063 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.647001e-02 | 1.063 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.657283e-02 | 1.063 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.657283e-02 | 1.063 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.916569e-02 | 1.050 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.166367e-02 | 1.038 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 9.367089e-02 | 1.028 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 9.367089e-02 | 1.028 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 9.367089e-02 | 1.028 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.413779e-02 | 1.026 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.637215e-02 | 1.016 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 9.637215e-02 | 1.016 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 9.637215e-02 | 1.016 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.182232e-01 | 0.927 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.182232e-01 | 0.927 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.182232e-01 | 0.927 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.058087e-01 | 0.975 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.113388e-01 | 0.953 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.133196e-01 | 0.946 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.880751e-02 | 1.005 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.774669e-02 | 1.010 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.072774e-01 | 0.969 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.072774e-01 | 0.969 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.825129e-02 | 1.008 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.825129e-02 | 1.008 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.031685e-01 | 0.986 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.077548e-01 | 0.968 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.051887e-01 | 0.978 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.058087e-01 | 0.975 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.154853e-01 | 0.937 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.140283e-01 | 0.943 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.140283e-01 | 0.943 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.182232e-01 | 0.927 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.119319e-01 | 0.951 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.094964e-01 | 0.961 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.059856e-01 | 0.975 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.113388e-01 | 0.953 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.177156e-01 | 0.929 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.136413e-01 | 0.944 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.177723e-01 | 0.929 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.095794e-01 | 0.960 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.072774e-01 | 0.969 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.182232e-01 | 0.927 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.730084e-02 | 1.012 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.169032e-01 | 0.932 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.192069e-01 | 0.924 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.192069e-01 | 0.924 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.192069e-01 | 0.924 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.192069e-01 | 0.924 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.227545e-01 | 0.911 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.227545e-01 | 0.911 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.265178e-01 | 0.898 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.271091e-01 | 0.896 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.271700e-01 | 0.896 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.271700e-01 | 0.896 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.271700e-01 | 0.896 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.271700e-01 | 0.896 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.272046e-01 | 0.895 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.272046e-01 | 0.895 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.283014e-01 | 0.892 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.283515e-01 | 0.892 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.283515e-01 | 0.892 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.283515e-01 | 0.892 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.283515e-01 | 0.892 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.284699e-01 | 0.891 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.287816e-01 | 0.890 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.287816e-01 | 0.890 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.290416e-01 | 0.889 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.290416e-01 | 0.889 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.290416e-01 | 0.889 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 1.290416e-01 | 0.889 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.290416e-01 | 0.889 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.290416e-01 | 0.889 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.309998e-01 | 0.883 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.434844e-01 | 0.843 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.434844e-01 | 0.843 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.434844e-01 | 0.843 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.434844e-01 | 0.843 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.434844e-01 | 0.843 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.649896e-01 | 0.783 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.649896e-01 | 0.783 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.649896e-01 | 0.783 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.452327e-01 | 0.838 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.452327e-01 | 0.838 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.743786e-01 | 0.759 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.743786e-01 | 0.759 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.503244e-01 | 0.823 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.750963e-01 | 0.757 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.505754e-01 | 0.822 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.722204e-01 | 0.764 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.450052e-01 | 0.839 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.450052e-01 | 0.839 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.587690e-01 | 0.799 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.330064e-01 | 0.876 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.497253e-01 | 0.825 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.678769e-01 | 0.775 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.587308e-01 | 0.799 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.487217e-01 | 0.828 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.452327e-01 | 0.838 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.452327e-01 | 0.838 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.609451e-01 | 0.793 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.503244e-01 | 0.823 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.337487e-01 | 0.874 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.743786e-01 | 0.759 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.318502e-01 | 0.880 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.661399e-01 | 0.780 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.486737e-01 | 0.828 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.358000e-01 | 0.867 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.733039e-01 | 0.761 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.484245e-01 | 0.828 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.722204e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.451906e-01 | 0.838 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.725957e-01 | 0.763 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.399395e-01 | 0.854 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.592068e-01 | 0.798 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.470958e-01 | 0.832 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.403745e-01 | 0.853 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.399395e-01 | 0.854 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.649026e-01 | 0.783 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.649026e-01 | 0.783 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.423797e-01 | 0.847 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.750963e-01 | 0.757 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.750963e-01 | 0.757 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.609451e-01 | 0.793 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.332751e-01 | 0.875 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.750963e-01 | 0.757 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.570871e-01 | 0.804 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.566986e-01 | 0.805 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.649896e-01 | 0.783 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.383201e-01 | 0.859 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.509283e-01 | 0.821 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.452069e-01 | 0.838 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.661399e-01 | 0.780 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.725957e-01 | 0.763 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.505754e-01 | 0.822 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.724476e-01 | 0.763 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.505754e-01 | 0.822 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.395607e-01 | 0.855 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.768652e-01 | 0.752 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.774963e-01 | 0.751 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.802750e-01 | 0.744 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.802750e-01 | 0.744 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.802750e-01 | 0.744 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.805688e-01 | 0.743 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.806286e-01 | 0.743 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.820205e-01 | 0.740 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.820205e-01 | 0.740 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.820205e-01 | 0.740 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.820205e-01 | 0.740 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.820205e-01 | 0.740 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.663881e-01 | 0.574 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.663881e-01 | 0.574 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.663881e-01 | 0.574 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.663881e-01 | 0.574 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.663881e-01 | 0.574 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.663881e-01 | 0.574 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.663881e-01 | 0.574 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.663881e-01 | 0.574 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.663881e-01 | 0.574 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.663881e-01 | 0.574 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.663881e-01 | 0.574 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.663881e-01 | 0.574 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.382378e-01 | 0.623 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.382378e-01 | 0.623 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.382378e-01 | 0.623 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.382378e-01 | 0.623 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.716621e-01 | 0.430 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.716621e-01 | 0.430 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.716621e-01 | 0.430 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.716621e-01 | 0.430 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.716621e-01 | 0.430 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.716621e-01 | 0.430 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.716621e-01 | 0.430 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.716621e-01 | 0.430 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.716621e-01 | 0.430 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.716621e-01 | 0.430 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.034580e-01 | 0.692 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.034580e-01 | 0.692 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.034580e-01 | 0.692 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.034580e-01 | 0.692 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.951683e-01 | 0.530 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.951683e-01 | 0.530 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.951683e-01 | 0.530 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.951683e-01 | 0.530 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.951683e-01 | 0.530 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.437159e-01 | 0.613 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.437159e-01 | 0.613 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.437159e-01 | 0.613 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.437159e-01 | 0.613 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.053153e-01 | 0.688 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.053153e-01 | 0.688 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.053153e-01 | 0.688 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.012904e-01 | 0.696 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.012904e-01 | 0.696 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.376865e-01 | 0.624 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.376865e-01 | 0.624 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.376865e-01 | 0.624 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.850853e-01 | 0.545 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.850853e-01 | 0.545 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.514503e-01 | 0.454 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.514503e-01 | 0.454 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.514503e-01 | 0.454 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.514503e-01 | 0.454 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.514503e-01 | 0.454 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.514503e-01 | 0.454 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.514503e-01 | 0.454 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.514503e-01 | 0.454 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.618343e-01 | 0.336 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.618343e-01 | 0.336 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.618343e-01 | 0.336 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.618343e-01 | 0.336 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.618343e-01 | 0.336 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.618343e-01 | 0.336 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.618343e-01 | 0.336 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.618343e-01 | 0.336 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.618343e-01 | 0.336 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.618343e-01 | 0.336 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.286980e-01 | 0.641 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.286980e-01 | 0.641 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.286980e-01 | 0.641 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.711372e-01 | 0.567 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.711372e-01 | 0.567 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.879736e-01 | 0.726 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.189527e-01 | 0.660 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.269557e-01 | 0.486 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.269557e-01 | 0.486 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.571032e-01 | 0.590 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.571032e-01 | 0.590 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.571032e-01 | 0.590 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.571032e-01 | 0.590 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.092040e-01 | 0.679 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.092040e-01 | 0.679 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.997423e-01 | 0.700 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.053238e-01 | 0.515 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.060982e-01 | 0.391 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 4.060982e-01 | 0.391 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.060982e-01 | 0.391 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.906807e-01 | 0.720 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.862882e-01 | 0.543 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.196305e-01 | 0.658 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.196305e-01 | 0.658 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.087741e-01 | 0.680 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.693397e-01 | 0.570 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.687918e-01 | 0.433 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.986385e-01 | 0.702 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.540805e-01 | 0.595 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.540805e-01 | 0.595 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.540805e-01 | 0.595 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.399211e-01 | 0.469 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.856214e-01 | 0.731 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.775121e-01 | 0.557 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.775121e-01 | 0.557 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.775121e-01 | 0.557 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.614174e-01 | 0.583 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.614174e-01 | 0.583 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.214507e-01 | 0.655 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.259458e-01 | 0.646 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.831498e-01 | 0.548 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.831498e-01 | 0.548 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.221935e-01 | 0.492 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.461441e-01 | 0.461 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.746277e-01 | 0.426 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.746277e-01 | 0.426 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.101357e-01 | 0.387 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.101357e-01 | 0.387 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.584222e-01 | 0.339 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.584222e-01 | 0.339 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.584222e-01 | 0.339 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.584222e-01 | 0.339 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.584222e-01 | 0.339 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 4.584222e-01 | 0.339 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.584222e-01 | 0.339 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.584222e-01 | 0.339 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 5.390705e-01 | 0.268 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.390705e-01 | 0.268 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.390705e-01 | 0.268 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 5.390705e-01 | 0.268 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.390705e-01 | 0.268 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 5.390705e-01 | 0.268 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.390705e-01 | 0.268 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.390705e-01 | 0.268 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.390705e-01 | 0.268 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.390705e-01 | 0.268 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.390705e-01 | 0.268 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.390705e-01 | 0.268 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.390705e-01 | 0.268 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.421281e-01 | 0.616 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.258067e-01 | 0.487 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.258067e-01 | 0.487 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.258067e-01 | 0.487 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.450908e-01 | 0.611 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.450908e-01 | 0.611 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.491727e-01 | 0.457 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.764083e-01 | 0.424 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.764083e-01 | 0.424 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.764083e-01 | 0.424 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.367945e-01 | 0.626 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 4.091695e-01 | 0.388 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.639865e-01 | 0.578 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.763282e-01 | 0.424 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.506047e-01 | 0.346 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.506639e-01 | 0.455 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.506639e-01 | 0.455 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.290652e-01 | 0.483 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.492954e-01 | 0.457 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.736507e-01 | 0.428 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.035235e-01 | 0.394 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.433023e-01 | 0.353 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.079641e-01 | 0.294 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.079641e-01 | 0.294 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.480745e-01 | 0.458 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.215267e-01 | 0.493 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.306296e-01 | 0.366 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.306296e-01 | 0.366 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.898877e-01 | 0.310 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.169295e-01 | 0.499 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.250440e-01 | 0.372 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.768121e-01 | 0.322 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.575265e-01 | 0.340 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.575265e-01 | 0.340 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.498004e-01 | 0.347 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.365828e-01 | 0.360 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.365828e-01 | 0.360 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.183801e-01 | 0.378 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.511652e-01 | 0.346 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.581282e-01 | 0.339 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.581282e-01 | 0.339 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.657894e-01 | 0.332 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.955414e-01 | 0.305 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.095154e-01 | 0.293 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.277393e-01 | 0.278 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.277393e-01 | 0.278 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.884914e-01 | 0.311 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.064941e-01 | 0.391 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.621300e-01 | 0.335 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.986029e-01 | 0.302 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.241033e-01 | 0.281 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.109231e-01 | 0.292 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.412581e-01 | 0.267 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.842877e-01 | 0.315 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.976531e-01 | 0.303 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.925752e-01 | 0.308 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.359068e-01 | 0.271 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.370335e-01 | 0.270 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.478737e-01 | 0.261 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.480695e-01 | 0.458 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.622065e-01 | 0.581 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.017234e-01 | 0.695 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.017234e-01 | 0.695 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.784223e-01 | 0.555 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.667547e-01 | 0.574 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.160379e-01 | 0.500 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.649071e-01 | 0.577 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.017234e-01 | 0.695 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.365828e-01 | 0.360 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.437159e-01 | 0.613 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.343488e-01 | 0.362 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.053153e-01 | 0.688 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.955333e-01 | 0.529 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.014582e-01 | 0.521 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.096047e-01 | 0.388 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.160379e-01 | 0.500 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.971352e-01 | 0.705 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.904058e-01 | 0.720 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.062548e-01 | 0.514 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.138958e-01 | 0.383 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.249192e-01 | 0.648 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.034580e-01 | 0.692 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.053153e-01 | 0.688 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.746277e-01 | 0.426 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.746277e-01 | 0.426 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 4.091695e-01 | 0.388 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.078344e-01 | 0.512 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.189527e-01 | 0.660 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.433335e-01 | 0.464 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.986120e-01 | 0.399 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.711372e-01 | 0.567 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.845729e-01 | 0.415 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.754796e-01 | 0.323 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.888595e-01 | 0.724 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.437159e-01 | 0.613 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.269557e-01 | 0.486 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.557724e-01 | 0.592 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.942998e-01 | 0.531 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.062548e-01 | 0.514 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.588342e-01 | 0.445 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.382378e-01 | 0.623 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.514503e-01 | 0.454 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.269557e-01 | 0.486 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.468749e-01 | 0.608 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.450908e-01 | 0.611 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.348786e-01 | 0.629 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.078344e-01 | 0.512 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.277393e-01 | 0.278 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.716984e-01 | 0.430 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.862882e-01 | 0.543 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.614174e-01 | 0.583 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.258067e-01 | 0.487 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.138464e-01 | 0.289 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.850853e-01 | 0.545 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.312665e-01 | 0.275 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.902266e-01 | 0.409 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.581282e-01 | 0.339 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.825501e-01 | 0.417 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.382378e-01 | 0.623 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.951683e-01 | 0.530 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.437159e-01 | 0.613 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.437159e-01 | 0.613 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.060982e-01 | 0.391 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.862882e-01 | 0.543 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.196305e-01 | 0.658 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.986385e-01 | 0.702 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.746277e-01 | 0.426 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.491727e-01 | 0.457 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.123544e-01 | 0.673 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.506047e-01 | 0.346 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.506047e-01 | 0.346 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.506639e-01 | 0.455 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.035235e-01 | 0.394 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.079641e-01 | 0.294 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.417466e-01 | 0.617 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.062548e-01 | 0.514 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 4.898877e-01 | 0.310 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.768121e-01 | 0.322 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.916027e-01 | 0.308 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.977997e-01 | 0.704 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.977997e-01 | 0.704 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.836401e-01 | 0.547 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.600792e-01 | 0.444 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.886233e-01 | 0.410 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.800892e-01 | 0.420 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.795469e-01 | 0.554 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.312747e-01 | 0.636 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.218709e-01 | 0.654 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.269557e-01 | 0.486 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.506047e-01 | 0.346 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.649006e-01 | 0.438 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.649006e-01 | 0.438 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.649006e-01 | 0.438 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.649006e-01 | 0.438 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.423147e-01 | 0.616 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.913395e-01 | 0.309 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.447399e-01 | 0.611 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.007502e-01 | 0.697 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.746277e-01 | 0.426 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.734514e-01 | 0.428 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.932981e-01 | 0.533 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.402332e-01 | 0.619 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.902446e-01 | 0.310 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.382378e-01 | 0.623 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.951683e-01 | 0.530 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.618343e-01 | 0.336 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.571032e-01 | 0.590 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 4.060982e-01 | 0.391 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.775121e-01 | 0.557 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.706843e-01 | 0.568 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.506047e-01 | 0.346 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.280391e-01 | 0.277 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.870978e-01 | 0.542 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.772462e-01 | 0.557 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.600792e-01 | 0.444 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.256589e-01 | 0.279 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.149537e-01 | 0.382 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.149537e-01 | 0.382 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.037656e-01 | 0.298 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.938134e-01 | 0.532 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.238460e-01 | 0.490 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.071788e-01 | 0.684 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.614174e-01 | 0.583 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.091695e-01 | 0.388 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.763282e-01 | 0.424 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.673329e-01 | 0.435 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.370174e-01 | 0.472 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.106594e-01 | 0.508 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.933037e-01 | 0.405 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.128248e-01 | 0.384 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.269557e-01 | 0.486 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.506639e-01 | 0.455 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.366799e-01 | 0.360 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.320411e-01 | 0.479 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.795302e-01 | 0.319 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.109231e-01 | 0.292 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.241033e-01 | 0.281 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.973811e-01 | 0.303 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.189527e-01 | 0.660 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.540805e-01 | 0.595 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.288939e-01 | 0.483 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.938041e-01 | 0.532 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.390569e-01 | 0.357 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.399368e-01 | 0.268 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.399368e-01 | 0.268 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.581282e-01 | 0.339 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.581282e-01 | 0.339 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.649006e-01 | 0.438 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.275262e-01 | 0.643 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.160379e-01 | 0.500 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.258067e-01 | 0.487 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.907822e-01 | 0.309 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.575265e-01 | 0.340 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.795302e-01 | 0.319 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.854614e-01 | 0.544 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.229299e-01 | 0.491 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.492688e-01 | 0.603 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.060036e-01 | 0.296 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.663881e-01 | 0.574 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.716621e-01 | 0.430 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.034580e-01 | 0.692 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.053153e-01 | 0.688 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.850853e-01 | 0.545 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.618343e-01 | 0.336 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 4.618343e-01 | 0.336 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.618343e-01 | 0.336 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.618343e-01 | 0.336 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.711372e-01 | 0.567 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.711372e-01 | 0.567 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.269557e-01 | 0.486 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.053238e-01 | 0.515 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.060982e-01 | 0.391 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.060982e-01 | 0.391 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.687918e-01 | 0.433 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.986385e-01 | 0.702 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.667547e-01 | 0.574 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.584222e-01 | 0.339 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.390705e-01 | 0.268 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.390705e-01 | 0.268 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.091695e-01 | 0.388 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.506047e-01 | 0.346 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.736507e-01 | 0.428 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 5.079641e-01 | 0.294 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.898877e-01 | 0.310 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.768121e-01 | 0.322 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.412581e-01 | 0.267 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.280299e-01 | 0.369 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.828240e-01 | 0.738 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.793992e-01 | 0.554 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.491727e-01 | 0.457 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.007323e-01 | 0.300 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.262222e-01 | 0.486 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.277393e-01 | 0.278 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.207741e-01 | 0.656 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.224896e-01 | 0.282 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.258618e-01 | 0.487 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.955414e-01 | 0.305 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.035235e-01 | 0.394 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.768121e-01 | 0.322 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.078344e-01 | 0.512 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.504465e-01 | 0.455 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.506978e-01 | 0.601 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.998074e-01 | 0.699 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.071788e-01 | 0.684 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.940149e-01 | 0.404 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.992946e-01 | 0.399 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.899079e-01 | 0.409 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.325046e-01 | 0.634 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.752688e-01 | 0.426 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.091346e-01 | 0.510 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.925752e-01 | 0.308 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.034580e-01 | 0.692 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.514503e-01 | 0.454 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.687918e-01 | 0.433 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.831498e-01 | 0.548 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.639865e-01 | 0.578 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.506047e-01 | 0.346 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.506047e-01 | 0.346 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.506047e-01 | 0.346 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.581282e-01 | 0.339 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.277393e-01 | 0.278 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.998728e-01 | 0.699 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.096047e-01 | 0.388 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.332606e-01 | 0.363 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.584222e-01 | 0.339 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.831498e-01 | 0.548 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.399211e-01 | 0.469 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.281099e-01 | 0.277 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.258493e-01 | 0.646 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.764083e-01 | 0.424 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.898877e-01 | 0.310 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.149537e-01 | 0.382 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.663591e-01 | 0.331 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.158418e-01 | 0.666 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.940118e-01 | 0.306 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.514503e-01 | 0.454 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.269557e-01 | 0.486 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.437627e-01 | 0.613 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.687918e-01 | 0.433 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.390705e-01 | 0.268 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.390705e-01 | 0.268 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.366799e-01 | 0.360 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.575265e-01 | 0.340 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.098404e-01 | 0.509 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.660764e-01 | 0.332 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.506639e-01 | 0.455 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.511652e-01 | 0.346 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.409769e-01 | 0.618 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.898877e-01 | 0.310 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.437627e-01 | 0.613 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.053267e-01 | 0.515 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.618343e-01 | 0.336 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.196305e-01 | 0.658 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.584222e-01 | 0.339 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.657894e-01 | 0.332 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.862882e-01 | 0.543 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.250440e-01 | 0.372 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.433023e-01 | 0.353 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.951683e-01 | 0.530 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.850853e-01 | 0.545 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.514503e-01 | 0.454 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.079641e-01 | 0.294 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.000449e-01 | 0.523 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.498004e-01 | 0.347 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.916027e-01 | 0.308 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.198398e-01 | 0.377 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.614174e-01 | 0.583 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.716984e-01 | 0.430 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.716984e-01 | 0.430 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.906807e-01 | 0.720 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.519376e-01 | 0.258 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.519376e-01 | 0.258 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.519376e-01 | 0.258 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.544449e-01 | 0.256 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.544449e-01 | 0.256 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.544449e-01 | 0.256 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.544449e-01 | 0.256 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.544449e-01 | 0.256 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.544449e-01 | 0.256 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.544449e-01 | 0.256 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.544449e-01 | 0.256 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.544449e-01 | 0.256 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.544449e-01 | 0.256 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.544449e-01 | 0.256 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.544449e-01 | 0.256 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.544449e-01 | 0.256 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.544449e-01 | 0.256 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.544449e-01 | 0.256 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.544449e-01 | 0.256 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.544449e-01 | 0.256 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.547395e-01 | 0.256 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.609634e-01 | 0.251 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.609634e-01 | 0.251 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.626303e-01 | 0.250 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.634268e-01 | 0.249 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.639733e-01 | 0.249 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.639733e-01 | 0.249 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.639733e-01 | 0.249 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.639733e-01 | 0.249 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.639733e-01 | 0.249 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.639733e-01 | 0.249 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.639733e-01 | 0.249 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.639733e-01 | 0.249 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.688887e-01 | 0.245 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.688887e-01 | 0.245 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.715856e-01 | 0.243 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.719144e-01 | 0.243 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.727679e-01 | 0.242 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.744831e-01 | 0.241 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.760195e-01 | 0.240 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.760195e-01 | 0.240 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.789536e-01 | 0.237 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.789536e-01 | 0.237 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.789536e-01 | 0.237 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.789536e-01 | 0.237 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.825435e-01 | 0.235 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.850436e-01 | 0.233 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.853609e-01 | 0.233 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.856346e-01 | 0.232 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.867254e-01 | 0.232 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.877011e-01 | 0.231 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.885857e-01 | 0.230 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.912846e-01 | 0.228 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.912846e-01 | 0.228 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.977227e-01 | 0.224 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.977227e-01 | 0.224 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.977227e-01 | 0.224 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.977227e-01 | 0.224 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.977227e-01 | 0.224 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.977227e-01 | 0.224 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.977227e-01 | 0.224 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.977227e-01 | 0.224 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.984561e-01 | 0.223 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.984561e-01 | 0.223 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.995507e-01 | 0.222 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.013848e-01 | 0.221 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.013848e-01 | 0.221 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.013848e-01 | 0.221 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.013848e-01 | 0.221 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.013848e-01 | 0.221 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.020322e-01 | 0.220 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.045860e-01 | 0.219 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.050757e-01 | 0.218 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.050757e-01 | 0.218 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.052257e-01 | 0.218 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 6.052257e-01 | 0.218 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 6.052257e-01 | 0.218 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.052257e-01 | 0.218 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 6.052257e-01 | 0.218 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 6.052257e-01 | 0.218 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.052257e-01 | 0.218 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.052257e-01 | 0.218 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.052257e-01 | 0.218 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 6.052257e-01 | 0.218 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 6.052257e-01 | 0.218 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 6.052257e-01 | 0.218 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 6.052257e-01 | 0.218 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.069708e-01 | 0.217 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.086537e-01 | 0.216 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.090404e-01 | 0.215 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.090404e-01 | 0.215 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.090404e-01 | 0.215 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.111155e-01 | 0.214 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.130791e-01 | 0.212 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.130791e-01 | 0.212 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.131643e-01 | 0.212 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.174495e-01 | 0.209 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.249459e-01 | 0.204 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.249459e-01 | 0.204 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.287397e-01 | 0.202 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.295940e-01 | 0.201 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.295940e-01 | 0.201 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.295940e-01 | 0.201 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.295940e-01 | 0.201 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.295940e-01 | 0.201 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.302434e-01 | 0.200 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.302434e-01 | 0.200 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.302434e-01 | 0.200 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.305418e-01 | 0.200 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.305418e-01 | 0.200 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.310994e-01 | 0.200 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.310994e-01 | 0.200 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.319530e-01 | 0.199 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.324421e-01 | 0.199 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.327957e-01 | 0.199 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.342318e-01 | 0.198 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.342318e-01 | 0.198 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.368299e-01 | 0.196 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.377595e-01 | 0.195 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.377595e-01 | 0.195 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.377595e-01 | 0.195 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.377595e-01 | 0.195 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.377595e-01 | 0.195 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.377595e-01 | 0.195 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.398495e-01 | 0.194 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.398495e-01 | 0.194 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.424864e-01 | 0.192 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.430133e-01 | 0.192 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.474938e-01 | 0.189 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.540588e-01 | 0.184 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.544100e-01 | 0.184 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.564888e-01 | 0.183 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.564888e-01 | 0.183 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.564888e-01 | 0.183 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.564888e-01 | 0.183 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.564888e-01 | 0.183 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.576430e-01 | 0.182 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.599800e-01 | 0.180 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.618541e-01 | 0.179 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.618541e-01 | 0.179 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.618541e-01 | 0.179 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.618541e-01 | 0.179 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.618541e-01 | 0.179 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.618541e-01 | 0.179 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.618892e-01 | 0.179 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.618892e-01 | 0.179 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.618892e-01 | 0.179 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.618892e-01 | 0.179 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.618892e-01 | 0.179 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.618892e-01 | 0.179 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.618892e-01 | 0.179 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.618892e-01 | 0.179 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.618892e-01 | 0.179 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.618892e-01 | 0.179 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.618892e-01 | 0.179 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.618892e-01 | 0.179 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.618892e-01 | 0.179 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.678492e-01 | 0.175 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.737318e-01 | 0.172 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.744839e-01 | 0.171 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.745940e-01 | 0.171 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.745940e-01 | 0.171 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.745940e-01 | 0.171 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 6.745940e-01 | 0.171 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.745940e-01 | 0.171 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.745940e-01 | 0.171 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.745940e-01 | 0.171 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.745940e-01 | 0.171 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.745940e-01 | 0.171 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.745940e-01 | 0.171 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.745940e-01 | 0.171 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.753272e-01 | 0.170 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.753272e-01 | 0.170 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.775414e-01 | 0.169 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.820355e-01 | 0.166 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.820355e-01 | 0.166 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.907039e-01 | 0.161 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.907039e-01 | 0.161 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.907039e-01 | 0.161 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.936799e-01 | 0.159 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.957356e-01 | 0.158 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.957356e-01 | 0.158 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.996155e-01 | 0.155 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.062178e-01 | 0.151 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.083206e-01 | 0.150 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.083206e-01 | 0.150 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.083206e-01 | 0.150 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.083206e-01 | 0.150 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.083206e-01 | 0.150 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.083206e-01 | 0.150 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.083206e-01 | 0.150 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.083206e-01 | 0.150 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.083206e-01 | 0.150 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.083206e-01 | 0.150 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.083206e-01 | 0.150 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.083206e-01 | 0.150 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.104223e-01 | 0.148 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.104223e-01 | 0.148 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.104223e-01 | 0.148 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.104223e-01 | 0.148 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.104223e-01 | 0.148 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.104223e-01 | 0.148 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.104223e-01 | 0.148 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.104223e-01 | 0.148 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.104223e-01 | 0.148 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.104223e-01 | 0.148 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.104223e-01 | 0.148 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 7.104223e-01 | 0.148 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 7.104223e-01 | 0.148 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.104223e-01 | 0.148 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 7.104223e-01 | 0.148 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.104223e-01 | 0.148 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 7.104223e-01 | 0.148 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.104223e-01 | 0.148 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.104223e-01 | 0.148 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.104223e-01 | 0.148 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 7.104223e-01 | 0.148 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 7.104223e-01 | 0.148 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 7.104223e-01 | 0.148 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 7.104223e-01 | 0.148 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.104223e-01 | 0.148 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.118478e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.118478e-01 | 0.148 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.118478e-01 | 0.148 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.152692e-01 | 0.146 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.176596e-01 | 0.144 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.176596e-01 | 0.144 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.176596e-01 | 0.144 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.176596e-01 | 0.144 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.206204e-01 | 0.142 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.206204e-01 | 0.142 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.206204e-01 | 0.142 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.206204e-01 | 0.142 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.223007e-01 | 0.141 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.244581e-01 | 0.140 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.290347e-01 | 0.137 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.290347e-01 | 0.137 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.294120e-01 | 0.137 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.326758e-01 | 0.135 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.339203e-01 | 0.134 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.339203e-01 | 0.134 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.339203e-01 | 0.134 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.363021e-01 | 0.133 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.390724e-01 | 0.131 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.390724e-01 | 0.131 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.390724e-01 | 0.131 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.390724e-01 | 0.131 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.390724e-01 | 0.131 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.390724e-01 | 0.131 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.390984e-01 | 0.131 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.395498e-01 | 0.131 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.405539e-01 | 0.130 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.411672e-01 | 0.130 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.427541e-01 | 0.129 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.427541e-01 | 0.129 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.427541e-01 | 0.129 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.427541e-01 | 0.129 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.427541e-01 | 0.129 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.427541e-01 | 0.129 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.427541e-01 | 0.129 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.427541e-01 | 0.129 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.462228e-01 | 0.127 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.468689e-01 | 0.127 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.471260e-01 | 0.127 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.471260e-01 | 0.127 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.504980e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.504980e-01 | 0.125 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.504980e-01 | 0.125 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.507629e-01 | 0.124 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.516874e-01 | 0.124 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.519913e-01 | 0.124 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.519913e-01 | 0.124 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.519913e-01 | 0.124 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.519913e-01 | 0.124 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.519913e-01 | 0.124 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.519913e-01 | 0.124 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.519913e-01 | 0.124 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.519913e-01 | 0.124 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.519913e-01 | 0.124 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.519913e-01 | 0.124 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.576413e-01 | 0.121 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.594219e-01 | 0.120 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.594219e-01 | 0.120 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.594219e-01 | 0.120 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.594219e-01 | 0.120 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.608335e-01 | 0.119 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.622799e-01 | 0.118 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.622799e-01 | 0.118 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.638278e-01 | 0.117 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.660380e-01 | 0.116 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.660380e-01 | 0.116 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.660380e-01 | 0.116 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.670085e-01 | 0.115 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.670085e-01 | 0.115 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.670085e-01 | 0.115 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.670085e-01 | 0.115 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.670085e-01 | 0.115 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.670085e-01 | 0.115 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.670085e-01 | 0.115 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.670085e-01 | 0.115 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.670085e-01 | 0.115 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.685747e-01 | 0.114 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.692666e-01 | 0.114 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.706304e-01 | 0.113 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.706304e-01 | 0.113 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.716318e-01 | 0.113 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.723012e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.723012e-01 | 0.112 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.772378e-01 | 0.109 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.775872e-01 | 0.109 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.782196e-01 | 0.109 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.785041e-01 | 0.109 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.845915e-01 | 0.105 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.863075e-01 | 0.104 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.863075e-01 | 0.104 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.868329e-01 | 0.104 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.875751e-01 | 0.104 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.875751e-01 | 0.104 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.875751e-01 | 0.104 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.875786e-01 | 0.104 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.875951e-01 | 0.104 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.875951e-01 | 0.104 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.875951e-01 | 0.104 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.875951e-01 | 0.104 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.875951e-01 | 0.104 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.875951e-01 | 0.104 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.875951e-01 | 0.104 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.875951e-01 | 0.104 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.875951e-01 | 0.104 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.875951e-01 | 0.104 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.875951e-01 | 0.104 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.875951e-01 | 0.104 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.875951e-01 | 0.104 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.875951e-01 | 0.104 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.875951e-01 | 0.104 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.875951e-01 | 0.104 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.878320e-01 | 0.104 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.894640e-01 | 0.103 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.894640e-01 | 0.103 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.894640e-01 | 0.103 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.894640e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.921202e-01 | 0.101 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.921520e-01 | 0.101 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.921520e-01 | 0.101 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.923033e-01 | 0.101 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.923033e-01 | 0.101 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.923033e-01 | 0.101 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.923033e-01 | 0.101 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.923033e-01 | 0.101 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.923033e-01 | 0.101 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.923033e-01 | 0.101 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.923033e-01 | 0.101 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.923033e-01 | 0.101 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.923033e-01 | 0.101 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.923033e-01 | 0.101 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.923033e-01 | 0.101 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.923033e-01 | 0.101 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.940210e-01 | 0.100 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.940210e-01 | 0.100 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.940210e-01 | 0.100 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.963038e-01 | 0.099 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.963038e-01 | 0.099 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.965056e-01 | 0.099 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.991583e-01 | 0.097 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.996667e-01 | 0.097 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.070379e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.070379e-01 | 0.093 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.070379e-01 | 0.093 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.070379e-01 | 0.093 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.074397e-01 | 0.093 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.074397e-01 | 0.093 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.074397e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.074397e-01 | 0.093 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.074397e-01 | 0.093 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.074397e-01 | 0.093 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.097962e-01 | 0.092 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.097962e-01 | 0.092 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.114674e-01 | 0.091 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.123878e-01 | 0.090 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.140728e-01 | 0.089 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.140728e-01 | 0.089 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.141275e-01 | 0.089 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.151394e-01 | 0.089 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.151394e-01 | 0.089 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.151394e-01 | 0.089 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.151394e-01 | 0.089 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.151394e-01 | 0.089 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.151394e-01 | 0.089 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.151394e-01 | 0.089 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.151394e-01 | 0.089 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.151394e-01 | 0.089 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.151394e-01 | 0.089 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.151394e-01 | 0.089 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.151394e-01 | 0.089 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.180894e-01 | 0.087 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.180894e-01 | 0.087 | 0 | 0 |
| RSK activation | R-HSA-444257 | 8.180894e-01 | 0.087 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.180894e-01 | 0.087 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.180894e-01 | 0.087 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.180894e-01 | 0.087 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 8.180894e-01 | 0.087 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 8.180894e-01 | 0.087 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.180894e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.180894e-01 | 0.087 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 8.180894e-01 | 0.087 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 8.180894e-01 | 0.087 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 8.180894e-01 | 0.087 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.180894e-01 | 0.087 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.180894e-01 | 0.087 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.180894e-01 | 0.087 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.180894e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.180894e-01 | 0.087 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 8.180894e-01 | 0.087 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.191004e-01 | 0.087 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.191004e-01 | 0.087 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.197428e-01 | 0.086 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.219266e-01 | 0.085 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.220410e-01 | 0.085 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.233972e-01 | 0.084 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.233972e-01 | 0.084 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.244819e-01 | 0.084 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.253859e-01 | 0.083 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.257129e-01 | 0.083 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.257129e-01 | 0.083 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.257129e-01 | 0.083 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.275755e-01 | 0.082 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.275755e-01 | 0.082 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.312071e-01 | 0.080 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.339002e-01 | 0.079 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.357013e-01 | 0.078 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.357013e-01 | 0.078 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.357013e-01 | 0.078 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.357013e-01 | 0.078 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.357013e-01 | 0.078 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.357013e-01 | 0.078 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.357013e-01 | 0.078 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.357013e-01 | 0.078 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.359623e-01 | 0.078 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.371546e-01 | 0.077 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.384424e-01 | 0.077 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.385914e-01 | 0.076 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.402835e-01 | 0.076 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.424808e-01 | 0.074 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.424808e-01 | 0.074 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.424808e-01 | 0.074 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.424808e-01 | 0.074 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.424808e-01 | 0.074 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.424808e-01 | 0.074 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.424808e-01 | 0.074 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.432430e-01 | 0.074 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.442072e-01 | 0.074 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.442072e-01 | 0.074 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 8.442072e-01 | 0.074 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.442072e-01 | 0.074 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.442072e-01 | 0.074 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.442072e-01 | 0.074 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.454801e-01 | 0.073 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.462668e-01 | 0.072 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.468436e-01 | 0.072 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.468436e-01 | 0.072 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.541712e-01 | 0.068 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.541712e-01 | 0.068 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.541712e-01 | 0.068 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.541712e-01 | 0.068 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.545323e-01 | 0.068 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.545323e-01 | 0.068 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.550827e-01 | 0.068 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.578317e-01 | 0.067 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.578317e-01 | 0.067 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.578317e-01 | 0.067 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.578317e-01 | 0.067 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.578317e-01 | 0.067 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.578317e-01 | 0.067 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.578317e-01 | 0.067 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.591986e-01 | 0.066 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.634469e-01 | 0.064 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.634491e-01 | 0.064 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.656977e-01 | 0.063 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.656977e-01 | 0.063 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.659627e-01 | 0.063 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.665765e-01 | 0.062 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.665765e-01 | 0.062 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.665765e-01 | 0.062 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.665765e-01 | 0.062 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.665765e-01 | 0.062 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.665765e-01 | 0.062 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.665765e-01 | 0.062 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.665765e-01 | 0.062 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 8.665765e-01 | 0.062 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.665765e-01 | 0.062 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.665765e-01 | 0.062 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.665765e-01 | 0.062 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.665765e-01 | 0.062 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.665765e-01 | 0.062 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.665765e-01 | 0.062 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.665765e-01 | 0.062 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.665765e-01 | 0.062 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.665765e-01 | 0.062 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.665765e-01 | 0.062 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.665765e-01 | 0.062 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.665765e-01 | 0.062 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.668754e-01 | 0.062 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.668754e-01 | 0.062 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.683645e-01 | 0.061 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.707259e-01 | 0.060 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.707259e-01 | 0.060 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.707259e-01 | 0.060 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.707259e-01 | 0.060 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.707259e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.718204e-01 | 0.060 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.718552e-01 | 0.060 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.718552e-01 | 0.060 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.731631e-01 | 0.059 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.746778e-01 | 0.058 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.746778e-01 | 0.058 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.746778e-01 | 0.058 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.760616e-01 | 0.057 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.777209e-01 | 0.057 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.777209e-01 | 0.057 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.777209e-01 | 0.057 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.806570e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.837078e-01 | 0.054 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.837429e-01 | 0.054 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.837429e-01 | 0.054 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.837429e-01 | 0.054 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 8.846400e-01 | 0.053 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.855343e-01 | 0.053 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.855343e-01 | 0.053 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.855343e-01 | 0.053 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.855343e-01 | 0.053 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.855343e-01 | 0.053 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.855343e-01 | 0.053 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.855343e-01 | 0.053 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.857350e-01 | 0.053 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.857350e-01 | 0.053 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.857350e-01 | 0.053 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.857350e-01 | 0.053 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.857350e-01 | 0.053 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.857350e-01 | 0.053 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.857350e-01 | 0.053 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.857350e-01 | 0.053 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.857350e-01 | 0.053 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.857350e-01 | 0.053 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.857350e-01 | 0.053 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.857350e-01 | 0.053 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.857350e-01 | 0.053 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.857350e-01 | 0.053 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.857350e-01 | 0.053 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.887993e-01 | 0.051 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.887993e-01 | 0.051 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.887993e-01 | 0.051 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.887993e-01 | 0.051 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.923780e-01 | 0.049 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.947958e-01 | 0.048 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.957632e-01 | 0.048 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.962733e-01 | 0.048 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.987567e-01 | 0.046 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.987567e-01 | 0.046 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.987567e-01 | 0.046 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.987567e-01 | 0.046 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.991814e-01 | 0.046 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.004655e-01 | 0.046 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.009588e-01 | 0.045 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 9.021434e-01 | 0.045 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 9.021434e-01 | 0.045 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 9.021434e-01 | 0.045 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 9.021434e-01 | 0.045 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 9.021434e-01 | 0.045 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.021434e-01 | 0.045 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 9.021434e-01 | 0.045 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.037635e-01 | 0.044 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.080299e-01 | 0.042 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.080299e-01 | 0.042 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.105431e-01 | 0.041 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.105431e-01 | 0.041 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.105431e-01 | 0.041 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.105431e-01 | 0.041 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.105431e-01 | 0.041 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.105431e-01 | 0.041 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.120572e-01 | 0.040 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.120572e-01 | 0.040 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.144727e-01 | 0.039 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.145539e-01 | 0.039 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.161964e-01 | 0.038 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 9.161964e-01 | 0.038 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.161964e-01 | 0.038 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 9.161964e-01 | 0.038 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.161964e-01 | 0.038 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.161964e-01 | 0.038 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.161964e-01 | 0.038 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 9.161964e-01 | 0.038 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.161964e-01 | 0.038 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.161964e-01 | 0.038 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.161964e-01 | 0.038 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 9.161964e-01 | 0.038 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.161964e-01 | 0.038 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.164216e-01 | 0.038 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.164216e-01 | 0.038 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.169255e-01 | 0.038 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.197165e-01 | 0.036 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.210331e-01 | 0.036 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.210331e-01 | 0.036 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.210331e-01 | 0.036 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.247787e-01 | 0.034 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.250960e-01 | 0.034 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.250960e-01 | 0.034 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.250960e-01 | 0.034 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.268364e-01 | 0.033 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.282320e-01 | 0.032 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.282320e-01 | 0.032 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 9.282320e-01 | 0.032 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.282320e-01 | 0.032 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.282320e-01 | 0.032 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.282320e-01 | 0.032 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.282320e-01 | 0.032 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.282320e-01 | 0.032 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.282320e-01 | 0.032 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.282320e-01 | 0.032 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.282320e-01 | 0.032 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.282320e-01 | 0.032 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.282320e-01 | 0.032 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.282320e-01 | 0.032 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.297442e-01 | 0.032 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.299041e-01 | 0.032 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.299041e-01 | 0.032 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.303559e-01 | 0.031 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.303559e-01 | 0.031 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.303559e-01 | 0.031 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.303559e-01 | 0.031 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.319571e-01 | 0.031 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.319571e-01 | 0.031 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.319571e-01 | 0.031 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.329372e-01 | 0.030 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.332846e-01 | 0.030 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.364692e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.385096e-01 | 0.028 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.385096e-01 | 0.028 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.385396e-01 | 0.028 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.385396e-01 | 0.028 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.385396e-01 | 0.028 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.385396e-01 | 0.028 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.385396e-01 | 0.028 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 9.385396e-01 | 0.028 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 9.385396e-01 | 0.028 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 9.385396e-01 | 0.028 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.385396e-01 | 0.028 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.385396e-01 | 0.028 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.385396e-01 | 0.028 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.385396e-01 | 0.028 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.385396e-01 | 0.028 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.385396e-01 | 0.028 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.385396e-01 | 0.028 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.385396e-01 | 0.028 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.386305e-01 | 0.028 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.386305e-01 | 0.028 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.386305e-01 | 0.028 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.386544e-01 | 0.027 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.392674e-01 | 0.027 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.416810e-01 | 0.026 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.422023e-01 | 0.026 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.422023e-01 | 0.026 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.422023e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.444827e-01 | 0.025 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.444827e-01 | 0.025 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.444827e-01 | 0.025 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.444827e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.459654e-01 | 0.024 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.459654e-01 | 0.024 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.459654e-01 | 0.024 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.463956e-01 | 0.024 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.473674e-01 | 0.023 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.473674e-01 | 0.023 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.473674e-01 | 0.023 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.473674e-01 | 0.023 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.473674e-01 | 0.023 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.473674e-01 | 0.023 | 0 | 0 |
| Events associated with phagocytolytic activity of PMN cells | R-HSA-8941413 | 9.473674e-01 | 0.023 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.473674e-01 | 0.023 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.479825e-01 | 0.023 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.486500e-01 | 0.023 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.498051e-01 | 0.022 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.498051e-01 | 0.022 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.498051e-01 | 0.022 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.499207e-01 | 0.022 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.499207e-01 | 0.022 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.510853e-01 | 0.022 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.510853e-01 | 0.022 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.510853e-01 | 0.022 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.515984e-01 | 0.022 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.521397e-01 | 0.021 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.521397e-01 | 0.021 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.521397e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.524599e-01 | 0.021 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.526924e-01 | 0.021 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.531500e-01 | 0.021 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.548653e-01 | 0.020 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.548653e-01 | 0.020 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.549276e-01 | 0.020 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.549276e-01 | 0.020 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.549276e-01 | 0.020 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.549276e-01 | 0.020 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.549276e-01 | 0.020 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.549276e-01 | 0.020 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.556355e-01 | 0.020 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.561609e-01 | 0.019 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.568071e-01 | 0.019 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.573045e-01 | 0.019 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.582040e-01 | 0.019 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.582040e-01 | 0.019 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.582040e-01 | 0.019 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.582040e-01 | 0.019 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.582040e-01 | 0.019 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.586548e-01 | 0.018 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.588973e-01 | 0.018 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.614022e-01 | 0.017 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.614022e-01 | 0.017 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.614022e-01 | 0.017 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.614022e-01 | 0.017 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.614022e-01 | 0.017 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.614022e-01 | 0.017 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.614022e-01 | 0.017 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.614022e-01 | 0.017 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.614022e-01 | 0.017 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.614022e-01 | 0.017 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.619431e-01 | 0.017 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.619431e-01 | 0.017 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.619431e-01 | 0.017 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.628944e-01 | 0.016 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.632793e-01 | 0.016 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.632793e-01 | 0.016 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.632793e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.634300e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.646749e-01 | 0.016 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.660534e-01 | 0.015 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.662651e-01 | 0.015 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.669471e-01 | 0.015 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.669471e-01 | 0.015 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.669471e-01 | 0.015 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.671216e-01 | 0.015 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.677593e-01 | 0.014 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.677593e-01 | 0.014 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.690657e-01 | 0.014 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.694851e-01 | 0.013 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.698336e-01 | 0.013 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.704634e-01 | 0.013 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.716956e-01 | 0.012 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.716956e-01 | 0.012 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.716956e-01 | 0.012 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.716956e-01 | 0.012 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.716956e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.716956e-01 | 0.012 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.716956e-01 | 0.012 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.716956e-01 | 0.012 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.716956e-01 | 0.012 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.726104e-01 | 0.012 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.731721e-01 | 0.012 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.751919e-01 | 0.011 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.751919e-01 | 0.011 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.757623e-01 | 0.011 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.757623e-01 | 0.011 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.757623e-01 | 0.011 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.757623e-01 | 0.011 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.761579e-01 | 0.010 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.765874e-01 | 0.010 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.773210e-01 | 0.010 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.777116e-01 | 0.010 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.782572e-01 | 0.010 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.785288e-01 | 0.009 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.787758e-01 | 0.009 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.788069e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.788258e-01 | 0.009 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.792448e-01 | 0.009 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.792448e-01 | 0.009 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.792448e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.792448e-01 | 0.009 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.792448e-01 | 0.009 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.803704e-01 | 0.009 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.822271e-01 | 0.008 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.822271e-01 | 0.008 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.822271e-01 | 0.008 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.822271e-01 | 0.008 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.822271e-01 | 0.008 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.822271e-01 | 0.008 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.822271e-01 | 0.008 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.822271e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.822271e-01 | 0.008 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.822271e-01 | 0.008 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.829026e-01 | 0.007 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.833250e-01 | 0.007 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.847811e-01 | 0.007 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.847811e-01 | 0.007 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.847811e-01 | 0.007 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.847811e-01 | 0.007 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.847811e-01 | 0.007 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.847811e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.853809e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.854080e-01 | 0.006 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.854080e-01 | 0.006 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.857748e-01 | 0.006 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.867550e-01 | 0.006 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.869681e-01 | 0.006 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.869681e-01 | 0.006 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.869681e-01 | 0.006 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.872368e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.872368e-01 | 0.006 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.872368e-01 | 0.006 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.872368e-01 | 0.006 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.873593e-01 | 0.006 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.877812e-01 | 0.005 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.888410e-01 | 0.005 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.888410e-01 | 0.005 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.888410e-01 | 0.005 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.888410e-01 | 0.005 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.888410e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.888415e-01 | 0.005 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.888415e-01 | 0.005 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.890890e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.890911e-01 | 0.005 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.901210e-01 | 0.004 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.904448e-01 | 0.004 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.904448e-01 | 0.004 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.904448e-01 | 0.004 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.904448e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.905327e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.907896e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.909308e-01 | 0.004 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.914820e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.914820e-01 | 0.004 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.918182e-01 | 0.004 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.918182e-01 | 0.004 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.918182e-01 | 0.004 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.918182e-01 | 0.004 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.918512e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.919833e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.929137e-01 | 0.003 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.929943e-01 | 0.003 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.929943e-01 | 0.003 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.931015e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.931015e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.931015e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.934257e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.935081e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.936470e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.936470e-01 | 0.003 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.940013e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.940013e-01 | 0.003 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.940013e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.943073e-01 | 0.002 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.943274e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.943358e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.943358e-01 | 0.002 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.945322e-01 | 0.002 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.948637e-01 | 0.002 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.948637e-01 | 0.002 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.948637e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.950597e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.950724e-01 | 0.002 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.956021e-01 | 0.002 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.956021e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.956021e-01 | 0.002 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.956021e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.956926e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.959167e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.961619e-01 | 0.002 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.962456e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.966632e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.967287e-01 | 0.001 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.967758e-01 | 0.001 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.967758e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.969679e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.969679e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.971506e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.971506e-01 | 0.001 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.972394e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.973089e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.974137e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.974841e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.976325e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.976364e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.978400e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.979979e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.982673e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.983143e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.983939e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.984524e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.984524e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.985165e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.985165e-01 | 0.001 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.986961e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.987182e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.987299e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.987299e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.987629e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.989126e-01 | 0.000 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.989126e-01 | 0.000 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.989126e-01 | 0.000 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.989126e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.990770e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.991556e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.991877e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.992018e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.992018e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.992029e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.992911e-01 | 0.000 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.992943e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.992946e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.993176e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.993783e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.994621e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.994714e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.994998e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.994998e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.995379e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.995456e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.995718e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.995813e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.995813e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.995813e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.996334e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.996519e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996661e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996788e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.996791e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.996827e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.996862e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.996862e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.996980e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.997077e-01 | 0.000 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.997313e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.997313e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.997535e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998029e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998152e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998152e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998267e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998291e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.998352e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.998363e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998403e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.998557e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.998557e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998559e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998887e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998899e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998943e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999350e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999445e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999514e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999530e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999695e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999695e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999717e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999720e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999739e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999777e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999827e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999836e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999836e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999858e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999860e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999860e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999880e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999901e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999906e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999925e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999929e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999939e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999942e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999945e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999948e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999953e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999954e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999960e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999964e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999981e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999983e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999984e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999987e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999988e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999989e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999989e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999990e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999990e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999996e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999997e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999998e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.886580e-15 | 14.540 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.265654e-13 | 12.898 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.629807e-13 | 12.788 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.701129e-13 | 12.013 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.885137e-12 | 11.540 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.558032e-11 | 10.592 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.421885e-11 | 10.616 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.016737e-08 | 7.993 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.219361e-08 | 7.654 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.665589e-08 | 7.115 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.956748e-08 | 7.048 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.580616e-07 | 6.801 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.671095e-07 | 6.573 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.118903e-07 | 6.506 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.525241e-07 | 6.453 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.189351e-07 | 6.378 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.472018e-07 | 6.349 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.729272e-07 | 6.325 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.304738e-07 | 6.275 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.027990e-07 | 6.220 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.480367e-07 | 6.188 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.390991e-07 | 6.131 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.628299e-07 | 6.016 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.858037e-07 | 6.006 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.643873e-06 | 5.784 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.800792e-06 | 5.745 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.995797e-06 | 5.700 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.068845e-06 | 5.684 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.438062e-06 | 5.613 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.949132e-06 | 5.530 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.275172e-06 | 5.485 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.798871e-06 | 5.420 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.798871e-06 | 5.420 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.798871e-06 | 5.420 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.899500e-06 | 5.409 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.782447e-06 | 5.320 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.782447e-06 | 5.320 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.605751e-06 | 5.251 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.935894e-06 | 5.227 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.650523e-06 | 5.116 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.009944e-06 | 5.096 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.989741e-06 | 5.000 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.035754e-05 | 4.985 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.165185e-05 | 4.934 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.153417e-05 | 4.938 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.280869e-05 | 4.892 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.280869e-05 | 4.892 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.399998e-05 | 4.854 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.597349e-05 | 4.797 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.606193e-05 | 4.794 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.738164e-05 | 4.760 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.019847e-05 | 4.695 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.994906e-05 | 4.700 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.433637e-05 | 4.614 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.497416e-05 | 4.603 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.604309e-05 | 4.584 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.604309e-05 | 4.584 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.550859e-05 | 4.593 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.671269e-05 | 4.573 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.759198e-05 | 4.559 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.067595e-05 | 4.513 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.258108e-05 | 4.487 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.394192e-05 | 4.469 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.465095e-05 | 4.460 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.798598e-05 | 4.420 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.238230e-05 | 4.373 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.757059e-05 | 4.323 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.744089e-05 | 4.241 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.469265e-05 | 4.189 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.756841e-05 | 4.170 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.739253e-05 | 4.111 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.094617e-05 | 4.092 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.252865e-05 | 4.083 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.750665e-05 | 4.011 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.642829e-05 | 4.016 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.086648e-04 | 3.964 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.138370e-04 | 3.944 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.155300e-04 | 3.937 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.280770e-04 | 3.893 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.280770e-04 | 3.893 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.280770e-04 | 3.893 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.280770e-04 | 3.893 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.319016e-04 | 3.880 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.313898e-04 | 3.881 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.319016e-04 | 3.880 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.389614e-04 | 3.857 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.407584e-04 | 3.852 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.613393e-04 | 3.792 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.617517e-04 | 3.791 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.756536e-04 | 3.755 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.986148e-04 | 3.702 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.921158e-04 | 3.716 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.910968e-04 | 3.719 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.003757e-04 | 3.698 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.999830e-04 | 3.699 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.911602e-04 | 3.719 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.993577e-04 | 3.700 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.158579e-04 | 3.666 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.214617e-04 | 3.655 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.234427e-04 | 3.651 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.296586e-04 | 3.639 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.464775e-04 | 3.608 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.819499e-04 | 3.550 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.087734e-04 | 3.510 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.193612e-04 | 3.496 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.296564e-04 | 3.482 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.514350e-04 | 3.454 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.576435e-04 | 3.447 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.995110e-04 | 3.398 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.321613e-04 | 3.364 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.341950e-04 | 3.362 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.682070e-04 | 3.330 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.714271e-04 | 3.327 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.714271e-04 | 3.327 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.813266e-04 | 3.318 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.907307e-04 | 3.309 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.304910e-04 | 3.275 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.015612e-04 | 3.300 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.417444e-04 | 3.266 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.106529e-04 | 3.292 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.425026e-04 | 3.266 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.536018e-04 | 3.257 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.634550e-04 | 3.249 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.641581e-04 | 3.249 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.721122e-04 | 3.243 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.721122e-04 | 3.243 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.804026e-04 | 3.236 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.187497e-04 | 3.143 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.746522e-04 | 3.171 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.164401e-04 | 3.145 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.447389e-04 | 3.128 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.795091e-04 | 3.108 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.866841e-04 | 3.104 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.866841e-04 | 3.104 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.939209e-04 | 3.100 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.095016e-04 | 3.092 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.095016e-04 | 3.092 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.247936e-04 | 3.084 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.627769e-04 | 3.064 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.731834e-04 | 3.059 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.807575e-04 | 3.055 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.306783e-04 | 3.031 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.053567e-03 | 2.977 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.763507e-04 | 3.010 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.074145e-03 | 2.969 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.093256e-03 | 2.961 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.097048e-03 | 2.960 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.152946e-03 | 2.938 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.190376e-03 | 2.924 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.334805e-03 | 2.875 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.334805e-03 | 2.875 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.358141e-03 | 2.867 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.401064e-03 | 2.854 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.413459e-03 | 2.850 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.674075e-03 | 2.776 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.581373e-03 | 2.801 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.642497e-03 | 2.784 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.559009e-03 | 2.807 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.691687e-03 | 2.772 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.691687e-03 | 2.772 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.729390e-03 | 2.762 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.732311e-03 | 2.761 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.744081e-03 | 2.758 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.809577e-03 | 2.742 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.858105e-03 | 2.731 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.869113e-03 | 2.728 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.936486e-03 | 2.713 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.952234e-03 | 2.709 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.999127e-03 | 2.699 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.071292e-03 | 2.684 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.115113e-03 | 2.675 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.427823e-03 | 2.615 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.298219e-03 | 2.639 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.381706e-03 | 2.623 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.287489e-03 | 2.641 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.473792e-03 | 2.607 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.567175e-03 | 2.591 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.660355e-03 | 2.575 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.728172e-03 | 2.564 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.869205e-03 | 2.542 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.873533e-03 | 2.542 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.903479e-03 | 2.537 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.921271e-03 | 2.534 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.955506e-03 | 2.529 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.365919e-03 | 2.473 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.365919e-03 | 2.473 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.087979e-03 | 2.510 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.018989e-03 | 2.520 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.348409e-03 | 2.475 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.390961e-03 | 2.470 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.401409e-03 | 2.468 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.010021e-03 | 2.521 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.222310e-03 | 2.492 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.010021e-03 | 2.521 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.087979e-03 | 2.510 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.427786e-03 | 2.465 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.489918e-03 | 2.457 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.665708e-03 | 2.436 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.766370e-03 | 2.424 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.766370e-03 | 2.424 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.766370e-03 | 2.424 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.769366e-03 | 2.424 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.813457e-03 | 2.419 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.981088e-03 | 2.400 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.982463e-03 | 2.400 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.001971e-03 | 2.398 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.048720e-03 | 2.393 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.048720e-03 | 2.393 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.048720e-03 | 2.393 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.048720e-03 | 2.393 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.058666e-03 | 2.392 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.069951e-03 | 2.390 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.212691e-03 | 2.375 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.212691e-03 | 2.375 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.212691e-03 | 2.375 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.177768e-03 | 2.379 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.758530e-03 | 2.323 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.212691e-03 | 2.375 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.246440e-03 | 2.372 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.901583e-03 | 2.310 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.935292e-03 | 2.307 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.007189e-03 | 2.300 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.007189e-03 | 2.300 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.008991e-03 | 2.300 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.096146e-03 | 2.293 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.220768e-03 | 2.282 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.373928e-03 | 2.270 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.408025e-03 | 2.267 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.426922e-03 | 2.265 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.497789e-03 | 2.260 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.497789e-03 | 2.260 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.497789e-03 | 2.260 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.497789e-03 | 2.260 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.757612e-03 | 2.240 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.893929e-03 | 2.230 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.893929e-03 | 2.230 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.009315e-03 | 2.221 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.009315e-03 | 2.221 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.040942e-03 | 2.219 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.090330e-03 | 2.215 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.091102e-03 | 2.215 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.181706e-03 | 2.209 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.259859e-03 | 2.203 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.259859e-03 | 2.203 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.147605e-03 | 2.146 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.320741e-03 | 2.135 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.511695e-03 | 2.124 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.682744e-03 | 2.114 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.656918e-03 | 2.116 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.819844e-03 | 2.107 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.250893e-03 | 2.140 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.819844e-03 | 2.107 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.727117e-03 | 2.172 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.721974e-03 | 2.173 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.770746e-03 | 2.169 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.819844e-03 | 2.107 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.767856e-03 | 2.170 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.106641e-03 | 2.148 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.828708e-03 | 2.166 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.053391e-03 | 2.094 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.352842e-03 | 2.078 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.449163e-03 | 2.073 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.494336e-03 | 2.071 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.494336e-03 | 2.071 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 8.494336e-03 | 2.071 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 8.494336e-03 | 2.071 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.632731e-03 | 2.064 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.732493e-03 | 2.059 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.830851e-03 | 2.054 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.904304e-03 | 2.050 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.150188e-03 | 2.039 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.478494e-03 | 2.023 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.499019e-03 | 2.022 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.855826e-03 | 2.006 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 9.855826e-03 | 2.006 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 9.855826e-03 | 2.006 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.855826e-03 | 2.006 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.034146e-02 | 1.985 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.041937e-02 | 1.982 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.046263e-02 | 1.980 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.065466e-02 | 1.972 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.065466e-02 | 1.972 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.086234e-02 | 1.964 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.087739e-02 | 1.963 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.118122e-02 | 1.952 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.134181e-02 | 1.945 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.134181e-02 | 1.945 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.209390e-02 | 1.917 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.209390e-02 | 1.917 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.209390e-02 | 1.917 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.209390e-02 | 1.917 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.215855e-02 | 1.915 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.215855e-02 | 1.915 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.215855e-02 | 1.915 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.216358e-02 | 1.915 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.216358e-02 | 1.915 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.216358e-02 | 1.915 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.227766e-02 | 1.911 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.284897e-02 | 1.891 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.353611e-02 | 1.869 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.690347e-02 | 1.772 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.557732e-02 | 1.808 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.557732e-02 | 1.808 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.610903e-02 | 1.793 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.517920e-02 | 1.819 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.734707e-02 | 1.761 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.722573e-02 | 1.764 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.651059e-02 | 1.782 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.517920e-02 | 1.819 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.614002e-02 | 1.792 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.480735e-02 | 1.830 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.529437e-02 | 1.815 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.753143e-02 | 1.756 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.753143e-02 | 1.756 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.779515e-02 | 1.750 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.779515e-02 | 1.750 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.799112e-02 | 1.745 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.848872e-02 | 1.733 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.869341e-02 | 1.728 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.877127e-02 | 1.727 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.877127e-02 | 1.727 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.906651e-02 | 1.720 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.930761e-02 | 1.714 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.954981e-02 | 1.709 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.977172e-02 | 1.704 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.977172e-02 | 1.704 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.977172e-02 | 1.704 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.032939e-02 | 1.692 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.099556e-02 | 1.678 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.117767e-02 | 1.674 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.189740e-02 | 1.660 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.198941e-02 | 1.658 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.199621e-02 | 1.658 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.199621e-02 | 1.658 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.199621e-02 | 1.658 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.205251e-02 | 1.657 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.221663e-02 | 1.653 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.222208e-02 | 1.653 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.229772e-02 | 1.652 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.229772e-02 | 1.652 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.361926e-02 | 1.627 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.414329e-02 | 1.617 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.419398e-02 | 1.616 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.419398e-02 | 1.616 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.419398e-02 | 1.616 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.419398e-02 | 1.616 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.419398e-02 | 1.616 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.419398e-02 | 1.616 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.419398e-02 | 1.616 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.425197e-02 | 1.615 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.425197e-02 | 1.615 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.474785e-02 | 1.606 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.487589e-02 | 1.604 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.501757e-02 | 1.602 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.501757e-02 | 1.602 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.501757e-02 | 1.602 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.531884e-02 | 1.597 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.562996e-02 | 1.591 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.618636e-02 | 1.582 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.618636e-02 | 1.582 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.618636e-02 | 1.582 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.567564e-02 | 1.448 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.760717e-02 | 1.559 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.290737e-02 | 1.483 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.290737e-02 | 1.483 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.060723e-02 | 1.514 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.060723e-02 | 1.514 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.689189e-02 | 1.570 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.228951e-02 | 1.491 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.857413e-02 | 1.544 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.039353e-02 | 1.517 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.689189e-02 | 1.570 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.290737e-02 | 1.483 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.832962e-02 | 1.548 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.505785e-02 | 1.455 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.178653e-02 | 1.498 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.392182e-02 | 1.470 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.290737e-02 | 1.483 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.755013e-02 | 1.560 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.832962e-02 | 1.548 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.726933e-02 | 1.564 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.178653e-02 | 1.498 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.228951e-02 | 1.491 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.031651e-02 | 1.518 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.217932e-02 | 1.492 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.505785e-02 | 1.455 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.689189e-02 | 1.570 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.701054e-02 | 1.568 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.993112e-02 | 1.524 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.689189e-02 | 1.570 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.928788e-02 | 1.533 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.570873e-02 | 1.447 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.640031e-02 | 1.439 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.709759e-02 | 1.431 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.735754e-02 | 1.428 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.783848e-02 | 1.422 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.822948e-02 | 1.418 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.822948e-02 | 1.418 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 3.882637e-02 | 1.411 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.889343e-02 | 1.410 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.942151e-02 | 1.404 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.062620e-02 | 1.391 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.062620e-02 | 1.391 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.062620e-02 | 1.391 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.065017e-02 | 1.391 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.073083e-02 | 1.390 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.089105e-02 | 1.388 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.113677e-02 | 1.386 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.113677e-02 | 1.386 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.127459e-02 | 1.384 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.127459e-02 | 1.384 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.127459e-02 | 1.384 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.127459e-02 | 1.384 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.147525e-02 | 1.382 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.170225e-02 | 1.380 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.170225e-02 | 1.380 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.183919e-02 | 1.378 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.187625e-02 | 1.378 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.279773e-02 | 1.369 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.328241e-02 | 1.364 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.452626e-02 | 1.351 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.492534e-02 | 1.348 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.492534e-02 | 1.348 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.492534e-02 | 1.348 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.516805e-02 | 1.345 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.524026e-02 | 1.344 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.527032e-02 | 1.344 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.538155e-02 | 1.343 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.540289e-02 | 1.343 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.583012e-02 | 1.339 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.678378e-02 | 1.330 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.678378e-02 | 1.330 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.724610e-02 | 1.326 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.724610e-02 | 1.326 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.756604e-02 | 1.323 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.952532e-02 | 1.225 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.952532e-02 | 1.225 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.952532e-02 | 1.225 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.952532e-02 | 1.225 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.952532e-02 | 1.225 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.004709e-02 | 1.222 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.004709e-02 | 1.222 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.072181e-02 | 1.295 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.072181e-02 | 1.295 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.072181e-02 | 1.295 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.072181e-02 | 1.295 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.206326e-02 | 1.207 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.206326e-02 | 1.207 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.921160e-02 | 1.308 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.815415e-02 | 1.235 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.796376e-02 | 1.168 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.012485e-02 | 1.221 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.227621e-02 | 1.282 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.051225e-02 | 1.297 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.828690e-02 | 1.316 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.202628e-02 | 1.143 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.182878e-02 | 1.209 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.318394e-02 | 1.274 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.212494e-02 | 1.283 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.212494e-02 | 1.283 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.051225e-02 | 1.297 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.839873e-02 | 1.234 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.064554e-02 | 1.217 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.206326e-02 | 1.207 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.051225e-02 | 1.297 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.364963e-02 | 1.196 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.500285e-02 | 1.187 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.500285e-02 | 1.187 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.111753e-02 | 1.214 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.111753e-02 | 1.214 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.227621e-02 | 1.282 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.598555e-02 | 1.252 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.598555e-02 | 1.252 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.202628e-02 | 1.143 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.099729e-02 | 1.149 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.099729e-02 | 1.149 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.712189e-02 | 1.173 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.403704e-02 | 1.267 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.980042e-02 | 1.156 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.815415e-02 | 1.235 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.258564e-02 | 1.279 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.804657e-02 | 1.167 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.012485e-02 | 1.221 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.111753e-02 | 1.214 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.044665e-02 | 1.219 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.750161e-02 | 1.240 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.227621e-02 | 1.282 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.306959e-02 | 1.275 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.810959e-02 | 1.318 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.952532e-02 | 1.225 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.004709e-02 | 1.222 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.206326e-02 | 1.207 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.206326e-02 | 1.207 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.796376e-02 | 1.168 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.319239e-02 | 1.274 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.012485e-02 | 1.221 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.141435e-02 | 1.289 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.762064e-02 | 1.170 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.636351e-02 | 1.249 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.198493e-02 | 1.143 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.868544e-02 | 1.231 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.004709e-02 | 1.222 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.072181e-02 | 1.295 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.206326e-02 | 1.207 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.796376e-02 | 1.168 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.702834e-02 | 1.244 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.815415e-02 | 1.235 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.892360e-02 | 1.230 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.500285e-02 | 1.187 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.202628e-02 | 1.143 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.809245e-02 | 1.318 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.896793e-02 | 1.161 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.227621e-02 | 1.282 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.289489e-02 | 1.137 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.462352e-02 | 1.127 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.462352e-02 | 1.127 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.462352e-02 | 1.127 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.462352e-02 | 1.127 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.462352e-02 | 1.127 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.462352e-02 | 1.127 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.462352e-02 | 1.127 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.462352e-02 | 1.127 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.462352e-02 | 1.127 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.557868e-02 | 1.122 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.599420e-02 | 1.119 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.618434e-02 | 1.118 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.681597e-02 | 1.115 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.681597e-02 | 1.115 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.681597e-02 | 1.115 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.681597e-02 | 1.115 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.761955e-02 | 1.110 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.814818e-02 | 1.107 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.814818e-02 | 1.107 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.863172e-02 | 1.104 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.863172e-02 | 1.104 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.863172e-02 | 1.104 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.863172e-02 | 1.104 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.919487e-02 | 1.101 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.949295e-02 | 1.100 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.949295e-02 | 1.100 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.972698e-02 | 1.098 | 0 | 0 |
| Translation | R-HSA-72766 | 8.001802e-02 | 1.097 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.161742e-02 | 1.088 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.247964e-02 | 1.084 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.256829e-02 | 1.083 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.321718e-02 | 1.080 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.351976e-02 | 1.078 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.351976e-02 | 1.078 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.387611e-02 | 1.076 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.410151e-02 | 1.075 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.666786e-02 | 1.062 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.734062e-02 | 1.059 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.734062e-02 | 1.059 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 8.734062e-02 | 1.059 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.740278e-02 | 1.058 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.740278e-02 | 1.058 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.799685e-02 | 1.056 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.836069e-02 | 1.054 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.897276e-02 | 1.051 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.014172e-02 | 1.045 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.014172e-02 | 1.045 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.083005e-02 | 1.042 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.128818e-02 | 1.040 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.207654e-02 | 1.036 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.255125e-02 | 1.034 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.315116e-02 | 1.031 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.346117e-02 | 1.029 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.346117e-02 | 1.029 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.346117e-02 | 1.029 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.538871e-02 | 1.021 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.538871e-02 | 1.021 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.568422e-02 | 1.019 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.568422e-02 | 1.019 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.575373e-02 | 1.019 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.575373e-02 | 1.019 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.575373e-02 | 1.019 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.656656e-02 | 1.015 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.670721e-02 | 1.015 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.700313e-02 | 1.013 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.845831e-02 | 1.007 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.845831e-02 | 1.007 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.915873e-02 | 1.004 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.016445e-01 | 0.993 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.026841e-01 | 0.988 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.027213e-01 | 0.988 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.032201e-01 | 0.986 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.032201e-01 | 0.986 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.040869e-01 | 0.983 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.040869e-01 | 0.983 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.045419e-01 | 0.981 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.045419e-01 | 0.981 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.077321e-01 | 0.968 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.077321e-01 | 0.968 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.081803e-01 | 0.966 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.095640e-01 | 0.960 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.095640e-01 | 0.960 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.128030e-01 | 0.948 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.128030e-01 | 0.948 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.128030e-01 | 0.948 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.128030e-01 | 0.948 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.133025e-01 | 0.946 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.133025e-01 | 0.946 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.137614e-01 | 0.944 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.146978e-01 | 0.940 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.153423e-01 | 0.938 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.155880e-01 | 0.937 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.155880e-01 | 0.937 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.155880e-01 | 0.937 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.155880e-01 | 0.937 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.155880e-01 | 0.937 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.155880e-01 | 0.937 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.155880e-01 | 0.937 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.155885e-01 | 0.937 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.155885e-01 | 0.937 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.155885e-01 | 0.937 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.155885e-01 | 0.937 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.781923e-01 | 0.749 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.781923e-01 | 0.749 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.781923e-01 | 0.749 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.781923e-01 | 0.749 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.781923e-01 | 0.749 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.781923e-01 | 0.749 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.781923e-01 | 0.749 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.781923e-01 | 0.749 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.781923e-01 | 0.749 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.781923e-01 | 0.749 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.781923e-01 | 0.749 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.181729e-01 | 0.927 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.181729e-01 | 0.927 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.181729e-01 | 0.927 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.512161e-01 | 0.820 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.512161e-01 | 0.820 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.857882e-01 | 0.731 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.857882e-01 | 0.731 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.857882e-01 | 0.731 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.213153e-01 | 0.655 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.601076e-01 | 0.796 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.191366e-01 | 0.924 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.360363e-01 | 0.866 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.360363e-01 | 0.866 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.360363e-01 | 0.866 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.840410e-01 | 0.735 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.538388e-01 | 0.813 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.088365e-01 | 0.680 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.724585e-01 | 0.763 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.724585e-01 | 0.763 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.724585e-01 | 0.763 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.440466e-01 | 0.841 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.440466e-01 | 0.841 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.233848e-01 | 0.909 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.751800e-01 | 0.757 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.117934e-01 | 0.674 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.916291e-01 | 0.718 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.323272e-01 | 0.634 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.323272e-01 | 0.634 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.323272e-01 | 0.634 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.323272e-01 | 0.634 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.323272e-01 | 0.634 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.323272e-01 | 0.634 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.260291e-01 | 0.646 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.260291e-01 | 0.646 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.260291e-01 | 0.646 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.409350e-01 | 0.851 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.409350e-01 | 0.851 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.409350e-01 | 0.851 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.409350e-01 | 0.851 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.660036e-01 | 0.780 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.508470e-01 | 0.821 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.143608e-01 | 0.669 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.239478e-01 | 0.907 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.051908e-01 | 0.688 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.175228e-01 | 0.930 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.724585e-01 | 0.763 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.088365e-01 | 0.680 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.260291e-01 | 0.646 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.508470e-01 | 0.821 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.916291e-01 | 0.718 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.916291e-01 | 0.718 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.561958e-01 | 0.806 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.372254e-01 | 0.863 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.840410e-01 | 0.735 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.538388e-01 | 0.813 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.372254e-01 | 0.863 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.191366e-01 | 0.924 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.440466e-01 | 0.841 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.233848e-01 | 0.909 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.354296e-01 | 0.868 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.473381e-01 | 0.832 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.981489e-01 | 0.703 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.840410e-01 | 0.735 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.088365e-01 | 0.680 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.212809e-01 | 0.916 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.344527e-01 | 0.871 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.624529e-01 | 0.789 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.017905e-01 | 0.695 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.017905e-01 | 0.695 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.840410e-01 | 0.735 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.260291e-01 | 0.646 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.374125e-01 | 0.862 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.374125e-01 | 0.862 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.374125e-01 | 0.862 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.374125e-01 | 0.862 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.597091e-01 | 0.797 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.211999e-01 | 0.916 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.881754e-01 | 0.725 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.213149e-01 | 0.916 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.272200e-01 | 0.644 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.464595e-01 | 0.834 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.464595e-01 | 0.834 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.030144e-01 | 0.692 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.964517e-01 | 0.707 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.964517e-01 | 0.707 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.624529e-01 | 0.789 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.295699e-01 | 0.639 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.656620e-01 | 0.781 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.088365e-01 | 0.680 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.182776e-01 | 0.661 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.857882e-01 | 0.731 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.857882e-01 | 0.731 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.601076e-01 | 0.796 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.233848e-01 | 0.909 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.737865e-01 | 0.760 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.254326e-01 | 0.902 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.213153e-01 | 0.655 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.323272e-01 | 0.634 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.547750e-01 | 0.810 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.374125e-01 | 0.862 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.083499e-01 | 0.681 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.150382e-01 | 0.667 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.918069e-01 | 0.717 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.335876e-01 | 0.874 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.532622e-01 | 0.815 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.781923e-01 | 0.749 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.181729e-01 | 0.927 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.213153e-01 | 0.655 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.088365e-01 | 0.680 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.918069e-01 | 0.717 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.182555e-01 | 0.661 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.916291e-01 | 0.718 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.191366e-01 | 0.924 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.547750e-01 | 0.810 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.547750e-01 | 0.810 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.904586e-01 | 0.720 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.180888e-01 | 0.928 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.718857e-01 | 0.765 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.538388e-01 | 0.813 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.895285e-01 | 0.722 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.597091e-01 | 0.797 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.857882e-01 | 0.731 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.857882e-01 | 0.731 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.030144e-01 | 0.692 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.507322e-01 | 0.822 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.272200e-01 | 0.644 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.182555e-01 | 0.661 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.313871e-01 | 0.636 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.374016e-01 | 0.862 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.536016e-01 | 0.814 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.881796e-01 | 0.725 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.180873e-01 | 0.928 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.220497e-01 | 0.654 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.111060e-01 | 0.675 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.335882e-01 | 0.874 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.213153e-01 | 0.655 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.360363e-01 | 0.866 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.182555e-01 | 0.661 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.465303e-01 | 0.834 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.895285e-01 | 0.722 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.234046e-01 | 0.909 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.191366e-01 | 0.924 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.972518e-01 | 0.705 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.814863e-01 | 0.741 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.294606e-01 | 0.888 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.881754e-01 | 0.725 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.712666e-01 | 0.766 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.624529e-01 | 0.789 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.624529e-01 | 0.789 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.260291e-01 | 0.646 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.507322e-01 | 0.822 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.538388e-01 | 0.813 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.334622e-01 | 0.875 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.918069e-01 | 0.717 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.873933e-01 | 0.727 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.360363e-01 | 0.866 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.964517e-01 | 0.707 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.234046e-01 | 0.909 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.234046e-01 | 0.909 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.338662e-01 | 0.631 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.343115e-01 | 0.630 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.343115e-01 | 0.630 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.343115e-01 | 0.630 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.343115e-01 | 0.630 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.343115e-01 | 0.630 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.343115e-01 | 0.630 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.381755e-01 | 0.623 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.381755e-01 | 0.623 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.400881e-01 | 0.620 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.403478e-01 | 0.619 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.410030e-01 | 0.618 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.410030e-01 | 0.618 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.416443e-01 | 0.617 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.464622e-01 | 0.608 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 2.498090e-01 | 0.602 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.518065e-01 | 0.599 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.526845e-01 | 0.597 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.526845e-01 | 0.597 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.526845e-01 | 0.597 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.533177e-01 | 0.596 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.533177e-01 | 0.596 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.533177e-01 | 0.596 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.533177e-01 | 0.596 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.535893e-01 | 0.596 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.550085e-01 | 0.593 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.550085e-01 | 0.593 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.550085e-01 | 0.593 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.550085e-01 | 0.593 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.550085e-01 | 0.593 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.550085e-01 | 0.593 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.550085e-01 | 0.593 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.550085e-01 | 0.593 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.550085e-01 | 0.593 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.550085e-01 | 0.593 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.550085e-01 | 0.593 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.550085e-01 | 0.593 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.550085e-01 | 0.593 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.573172e-01 | 0.590 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.573172e-01 | 0.590 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.573172e-01 | 0.590 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.573172e-01 | 0.590 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.573172e-01 | 0.590 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.573172e-01 | 0.590 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.573172e-01 | 0.590 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.573172e-01 | 0.590 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.599906e-01 | 0.585 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.602924e-01 | 0.585 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.602924e-01 | 0.585 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.620664e-01 | 0.582 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.620664e-01 | 0.582 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.623866e-01 | 0.581 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.645338e-01 | 0.578 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.660459e-01 | 0.575 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.660459e-01 | 0.575 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.673244e-01 | 0.573 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.674480e-01 | 0.573 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.674480e-01 | 0.573 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.674480e-01 | 0.573 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.674480e-01 | 0.573 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.705985e-01 | 0.568 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.727700e-01 | 0.564 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.746761e-01 | 0.561 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.746761e-01 | 0.561 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.746761e-01 | 0.561 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.746761e-01 | 0.561 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.746761e-01 | 0.561 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.746761e-01 | 0.561 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.761364e-01 | 0.559 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.790826e-01 | 0.554 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.805606e-01 | 0.552 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.805606e-01 | 0.552 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.805606e-01 | 0.552 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.805606e-01 | 0.552 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.811744e-01 | 0.551 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.816235e-01 | 0.550 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.816235e-01 | 0.550 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.847118e-01 | 0.546 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.866165e-01 | 0.543 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.866165e-01 | 0.543 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.866165e-01 | 0.543 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.866165e-01 | 0.543 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.866165e-01 | 0.543 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.866165e-01 | 0.543 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.866165e-01 | 0.543 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.866165e-01 | 0.543 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.866165e-01 | 0.543 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.900604e-01 | 0.538 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.920925e-01 | 0.534 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.927132e-01 | 0.534 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.933952e-01 | 0.533 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 2.933952e-01 | 0.533 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.933952e-01 | 0.533 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.933952e-01 | 0.533 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.943932e-01 | 0.531 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.951179e-01 | 0.530 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.963162e-01 | 0.528 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.963162e-01 | 0.528 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.963162e-01 | 0.528 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.976251e-01 | 0.526 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.992487e-01 | 0.524 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.992487e-01 | 0.524 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.992986e-01 | 0.524 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.992986e-01 | 0.524 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.131324e-01 | 0.504 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.131324e-01 | 0.504 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.131324e-01 | 0.504 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.131324e-01 | 0.504 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.161382e-01 | 0.500 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.181545e-01 | 0.497 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.204971e-01 | 0.494 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.246487e-01 | 0.489 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.246487e-01 | 0.489 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.246487e-01 | 0.489 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.246487e-01 | 0.489 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.246487e-01 | 0.489 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.264414e-01 | 0.486 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.284790e-01 | 0.483 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.292208e-01 | 0.483 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.292208e-01 | 0.483 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.292208e-01 | 0.483 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.292208e-01 | 0.483 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.292208e-01 | 0.483 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.292208e-01 | 0.483 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.292208e-01 | 0.483 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.292208e-01 | 0.483 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.292208e-01 | 0.483 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.292208e-01 | 0.483 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.372919e-01 | 0.472 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.372919e-01 | 0.472 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.372919e-01 | 0.472 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.372919e-01 | 0.472 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.379516e-01 | 0.471 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.379516e-01 | 0.471 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.388178e-01 | 0.470 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.397010e-01 | 0.469 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.401116e-01 | 0.468 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.401116e-01 | 0.468 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.498670e-01 | 0.456 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.503054e-01 | 0.456 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.503054e-01 | 0.456 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.503054e-01 | 0.456 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.621118e-01 | 0.441 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.621118e-01 | 0.441 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.621118e-01 | 0.441 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.621118e-01 | 0.441 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.621118e-01 | 0.441 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.645261e-01 | 0.438 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.645261e-01 | 0.438 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.645261e-01 | 0.438 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.645261e-01 | 0.438 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.645261e-01 | 0.438 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.645261e-01 | 0.438 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.645261e-01 | 0.438 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.645261e-01 | 0.438 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.645261e-01 | 0.438 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.645261e-01 | 0.438 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.661957e-01 | 0.436 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.661957e-01 | 0.436 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.661957e-01 | 0.436 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.661957e-01 | 0.436 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.675102e-01 | 0.435 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.727045e-01 | 0.429 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.727985e-01 | 0.429 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.755356e-01 | 0.425 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.756333e-01 | 0.425 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.756333e-01 | 0.425 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.756333e-01 | 0.425 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.782809e-01 | 0.422 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.840842e-01 | 0.416 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.840842e-01 | 0.416 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.840842e-01 | 0.416 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.840842e-01 | 0.416 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.840842e-01 | 0.416 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.842394e-01 | 0.415 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.847486e-01 | 0.415 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.861545e-01 | 0.413 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.863980e-01 | 0.413 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.877827e-01 | 0.411 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 3.877827e-01 | 0.411 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.877827e-01 | 0.411 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.877827e-01 | 0.411 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.877827e-01 | 0.411 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.877827e-01 | 0.411 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.908457e-01 | 0.408 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.925024e-01 | 0.406 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.925024e-01 | 0.406 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.925024e-01 | 0.406 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.925024e-01 | 0.406 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.925024e-01 | 0.406 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.925024e-01 | 0.406 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.948134e-01 | 0.404 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.957059e-01 | 0.403 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.962691e-01 | 0.402 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.962691e-01 | 0.402 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.981322e-01 | 0.400 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.990955e-01 | 0.399 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.990955e-01 | 0.399 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.990955e-01 | 0.399 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.990955e-01 | 0.399 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.990955e-01 | 0.399 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.990955e-01 | 0.399 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.076944e-01 | 0.390 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.138483e-01 | 0.383 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.139395e-01 | 0.383 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.139395e-01 | 0.383 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.185191e-01 | 0.378 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.185191e-01 | 0.378 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.185191e-01 | 0.378 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.185191e-01 | 0.378 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.185191e-01 | 0.378 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.194458e-01 | 0.377 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.240091e-01 | 0.373 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.276847e-01 | 0.369 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.276847e-01 | 0.369 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.276847e-01 | 0.369 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.276847e-01 | 0.369 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.307416e-01 | 0.366 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.327582e-01 | 0.364 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.327582e-01 | 0.364 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.327582e-01 | 0.364 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.327582e-01 | 0.364 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.327582e-01 | 0.364 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.327582e-01 | 0.364 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.336019e-01 | 0.363 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.351290e-01 | 0.361 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.363339e-01 | 0.360 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.363339e-01 | 0.360 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.363339e-01 | 0.360 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.385971e-01 | 0.358 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.431631e-01 | 0.353 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.441557e-01 | 0.352 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.450182e-01 | 0.352 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.450182e-01 | 0.352 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.450182e-01 | 0.352 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.450182e-01 | 0.352 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.450182e-01 | 0.352 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.450182e-01 | 0.352 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.450182e-01 | 0.352 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.450182e-01 | 0.352 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.450182e-01 | 0.352 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.450182e-01 | 0.352 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.450182e-01 | 0.352 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.450182e-01 | 0.352 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.450182e-01 | 0.352 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.491946e-01 | 0.348 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.491946e-01 | 0.348 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.518640e-01 | 0.345 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.537336e-01 | 0.343 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.548633e-01 | 0.342 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.653817e-01 | 0.332 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.653817e-01 | 0.332 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.653817e-01 | 0.332 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.653817e-01 | 0.332 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.653817e-01 | 0.332 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.653817e-01 | 0.332 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.663682e-01 | 0.331 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.663682e-01 | 0.331 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.678333e-01 | 0.330 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.692119e-01 | 0.329 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.693336e-01 | 0.329 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.703081e-01 | 0.328 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.704404e-01 | 0.327 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.704404e-01 | 0.327 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.705856e-01 | 0.327 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.705856e-01 | 0.327 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.745491e-01 | 0.324 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.793022e-01 | 0.319 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.793022e-01 | 0.319 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.836135e-01 | 0.316 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 4.852719e-01 | 0.314 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.879651e-01 | 0.312 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.891001e-01 | 0.311 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.891001e-01 | 0.311 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.891001e-01 | 0.311 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.913753e-01 | 0.309 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.939846e-01 | 0.306 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.968662e-01 | 0.304 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.968662e-01 | 0.304 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.968662e-01 | 0.304 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.968662e-01 | 0.304 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.968662e-01 | 0.304 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.968662e-01 | 0.304 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.969058e-01 | 0.304 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.969058e-01 | 0.304 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.969058e-01 | 0.304 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.969058e-01 | 0.304 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.969058e-01 | 0.304 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.969058e-01 | 0.304 | 0 | 0 |
| Hydroxycarboxylic acid-binding receptors | R-HSA-3296197 | 4.969058e-01 | 0.304 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.969058e-01 | 0.304 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.969058e-01 | 0.304 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.969058e-01 | 0.304 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.969058e-01 | 0.304 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.969058e-01 | 0.304 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 4.969058e-01 | 0.304 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.969058e-01 | 0.304 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.969058e-01 | 0.304 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.969058e-01 | 0.304 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.969058e-01 | 0.304 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.060638e-01 | 0.296 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.073759e-01 | 0.295 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.073759e-01 | 0.295 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.119573e-01 | 0.291 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.119573e-01 | 0.291 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.126883e-01 | 0.290 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.180511e-01 | 0.286 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.200998e-01 | 0.284 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.210902e-01 | 0.283 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.271394e-01 | 0.278 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.271394e-01 | 0.278 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.271394e-01 | 0.278 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.271394e-01 | 0.278 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.271394e-01 | 0.278 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 5.271394e-01 | 0.278 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 5.271394e-01 | 0.278 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 5.271394e-01 | 0.278 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.271394e-01 | 0.278 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.271394e-01 | 0.278 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.271394e-01 | 0.278 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.271394e-01 | 0.278 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.271394e-01 | 0.278 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.321490e-01 | 0.274 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.321490e-01 | 0.274 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.321490e-01 | 0.274 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.321490e-01 | 0.274 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.321490e-01 | 0.274 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.360811e-01 | 0.271 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.430978e-01 | 0.265 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.434804e-01 | 0.265 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.439450e-01 | 0.264 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.439450e-01 | 0.264 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.439450e-01 | 0.264 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.439450e-01 | 0.264 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.439450e-01 | 0.264 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.439450e-01 | 0.264 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.439450e-01 | 0.264 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.439450e-01 | 0.264 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.439450e-01 | 0.264 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.439450e-01 | 0.264 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.439450e-01 | 0.264 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.439450e-01 | 0.264 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.439450e-01 | 0.264 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.439450e-01 | 0.264 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.439450e-01 | 0.264 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.439450e-01 | 0.264 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.439450e-01 | 0.264 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.439450e-01 | 0.264 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.439450e-01 | 0.264 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.439450e-01 | 0.264 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.439450e-01 | 0.264 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.519178e-01 | 0.258 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.519178e-01 | 0.258 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.519178e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.533342e-01 | 0.257 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.561528e-01 | 0.255 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.561528e-01 | 0.255 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.561528e-01 | 0.255 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.561528e-01 | 0.255 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.561528e-01 | 0.255 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.561528e-01 | 0.255 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.642455e-01 | 0.249 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.642455e-01 | 0.249 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.642455e-01 | 0.249 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.712351e-01 | 0.243 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.738200e-01 | 0.241 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.775511e-01 | 0.238 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.775511e-01 | 0.238 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.775511e-01 | 0.238 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.838772e-01 | 0.234 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.838772e-01 | 0.234 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.838772e-01 | 0.234 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.838772e-01 | 0.234 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.838772e-01 | 0.234 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.838772e-01 | 0.234 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.838772e-01 | 0.234 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.853853e-01 | 0.233 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.863022e-01 | 0.232 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.863022e-01 | 0.232 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.863022e-01 | 0.232 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.863022e-01 | 0.232 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.865886e-01 | 0.232 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.865886e-01 | 0.232 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.865886e-01 | 0.232 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.865886e-01 | 0.232 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.865886e-01 | 0.232 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.865886e-01 | 0.232 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.865886e-01 | 0.232 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 5.865886e-01 | 0.232 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.865886e-01 | 0.232 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.865886e-01 | 0.232 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.900766e-01 | 0.229 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.910923e-01 | 0.228 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.938893e-01 | 0.226 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.942505e-01 | 0.226 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.985085e-01 | 0.223 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.067671e-01 | 0.217 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.068627e-01 | 0.217 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.068627e-01 | 0.217 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.076303e-01 | 0.216 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.076303e-01 | 0.216 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.076303e-01 | 0.216 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.076303e-01 | 0.216 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.103000e-01 | 0.214 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.103000e-01 | 0.214 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.103000e-01 | 0.214 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.103000e-01 | 0.214 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 6.103000e-01 | 0.214 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.196207e-01 | 0.208 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.252471e-01 | 0.204 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.252471e-01 | 0.204 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.252471e-01 | 0.204 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.252471e-01 | 0.204 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.252471e-01 | 0.204 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.252471e-01 | 0.204 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.252471e-01 | 0.204 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.252471e-01 | 0.204 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.252471e-01 | 0.204 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.252471e-01 | 0.204 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.254804e-01 | 0.204 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.261415e-01 | 0.203 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.265132e-01 | 0.203 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.282122e-01 | 0.202 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.282122e-01 | 0.202 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.282122e-01 | 0.202 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.354222e-01 | 0.197 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.354222e-01 | 0.197 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.388566e-01 | 0.195 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.420507e-01 | 0.192 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.420507e-01 | 0.192 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.420507e-01 | 0.192 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.435607e-01 | 0.191 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.435607e-01 | 0.191 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.435607e-01 | 0.191 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.480364e-01 | 0.188 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.480364e-01 | 0.188 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.480364e-01 | 0.188 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.592559e-01 | 0.181 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.592559e-01 | 0.181 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.592559e-01 | 0.181 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.592559e-01 | 0.181 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.602927e-01 | 0.180 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.602927e-01 | 0.180 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.602927e-01 | 0.180 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.602927e-01 | 0.180 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.602927e-01 | 0.180 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.602927e-01 | 0.180 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.602927e-01 | 0.180 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.603309e-01 | 0.180 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.688061e-01 | 0.175 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.696812e-01 | 0.174 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.727762e-01 | 0.172 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.754435e-01 | 0.170 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.754435e-01 | 0.170 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.754435e-01 | 0.170 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.765580e-01 | 0.170 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.765580e-01 | 0.170 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.818225e-01 | 0.166 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.826935e-01 | 0.166 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.853913e-01 | 0.164 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.853913e-01 | 0.164 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.890051e-01 | 0.162 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.911147e-01 | 0.160 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.920628e-01 | 0.160 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.920628e-01 | 0.160 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.920628e-01 | 0.160 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.920628e-01 | 0.160 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.920628e-01 | 0.160 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.920628e-01 | 0.160 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.920628e-01 | 0.160 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.920628e-01 | 0.160 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.920628e-01 | 0.160 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.920628e-01 | 0.160 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.920628e-01 | 0.160 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.920628e-01 | 0.160 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.920628e-01 | 0.160 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.920628e-01 | 0.160 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.029233e-01 | 0.153 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.031504e-01 | 0.153 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.031504e-01 | 0.153 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.031504e-01 | 0.153 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.031504e-01 | 0.153 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.031504e-01 | 0.153 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.031504e-01 | 0.153 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.045267e-01 | 0.152 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.045267e-01 | 0.152 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.073681e-01 | 0.150 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.208634e-01 | 0.142 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.208634e-01 | 0.142 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.208634e-01 | 0.142 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.208634e-01 | 0.142 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.208634e-01 | 0.142 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.208634e-01 | 0.142 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.208634e-01 | 0.142 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.208634e-01 | 0.142 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.208634e-01 | 0.142 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.208634e-01 | 0.142 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.208634e-01 | 0.142 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.232739e-01 | 0.141 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.232739e-01 | 0.141 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.232739e-01 | 0.141 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.357284e-01 | 0.133 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.357284e-01 | 0.133 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.390358e-01 | 0.131 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.422316e-01 | 0.129 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.422316e-01 | 0.129 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.422316e-01 | 0.129 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.422316e-01 | 0.129 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.466187e-01 | 0.127 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.469719e-01 | 0.127 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.469719e-01 | 0.127 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.469719e-01 | 0.127 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.469719e-01 | 0.127 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.469719e-01 | 0.127 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.469719e-01 | 0.127 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.469719e-01 | 0.127 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.469719e-01 | 0.127 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.469719e-01 | 0.127 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.469719e-01 | 0.127 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.469719e-01 | 0.127 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.485810e-01 | 0.126 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.494798e-01 | 0.125 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.510236e-01 | 0.124 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.510236e-01 | 0.124 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.510236e-01 | 0.124 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.600656e-01 | 0.119 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.600656e-01 | 0.119 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.600656e-01 | 0.119 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.624386e-01 | 0.118 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.624386e-01 | 0.118 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.624386e-01 | 0.118 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.628913e-01 | 0.118 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.655995e-01 | 0.116 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.655995e-01 | 0.116 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.685118e-01 | 0.114 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.706397e-01 | 0.113 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.706397e-01 | 0.113 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.706397e-01 | 0.113 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 7.706397e-01 | 0.113 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.748695e-01 | 0.111 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.768202e-01 | 0.110 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.768202e-01 | 0.110 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.768202e-01 | 0.110 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 7.768202e-01 | 0.110 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.850610e-01 | 0.105 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.874274e-01 | 0.104 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.920950e-01 | 0.101 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 7.920950e-01 | 0.101 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 7.920950e-01 | 0.101 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.920950e-01 | 0.101 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.920950e-01 | 0.101 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.920950e-01 | 0.101 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.920950e-01 | 0.101 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.920950e-01 | 0.101 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.920950e-01 | 0.101 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.920950e-01 | 0.101 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.920950e-01 | 0.101 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.920950e-01 | 0.101 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.920950e-01 | 0.101 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.925412e-01 | 0.101 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.925412e-01 | 0.101 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.926626e-01 | 0.101 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.955266e-01 | 0.099 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.968550e-01 | 0.099 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.985002e-01 | 0.098 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.046094e-01 | 0.094 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.072753e-01 | 0.093 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.115445e-01 | 0.091 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.115445e-01 | 0.091 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.115445e-01 | 0.091 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.115445e-01 | 0.091 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.115445e-01 | 0.091 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.115445e-01 | 0.091 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.170697e-01 | 0.088 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.177183e-01 | 0.087 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.195098e-01 | 0.086 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.210695e-01 | 0.086 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.210695e-01 | 0.086 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.210695e-01 | 0.086 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.217360e-01 | 0.085 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.243888e-01 | 0.084 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.243888e-01 | 0.084 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.283297e-01 | 0.082 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.283297e-01 | 0.082 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.291755e-01 | 0.081 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.291755e-01 | 0.081 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.291755e-01 | 0.081 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.291755e-01 | 0.081 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.291755e-01 | 0.081 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.291755e-01 | 0.081 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.334223e-01 | 0.079 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.339707e-01 | 0.079 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.339707e-01 | 0.079 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.339707e-01 | 0.079 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.339707e-01 | 0.079 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.389419e-01 | 0.076 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.389900e-01 | 0.076 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.389900e-01 | 0.076 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.389900e-01 | 0.076 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.438354e-01 | 0.074 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.451579e-01 | 0.073 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.451579e-01 | 0.073 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.451579e-01 | 0.073 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.451579e-01 | 0.073 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.451579e-01 | 0.073 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.451579e-01 | 0.073 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.451579e-01 | 0.073 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.460253e-01 | 0.073 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.460253e-01 | 0.073 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.469726e-01 | 0.072 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.479812e-01 | 0.072 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.490732e-01 | 0.071 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.515559e-01 | 0.070 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.572785e-01 | 0.067 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.572785e-01 | 0.067 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.572785e-01 | 0.067 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.572785e-01 | 0.067 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.586021e-01 | 0.066 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 8.596459e-01 | 0.066 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.596459e-01 | 0.066 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.596459e-01 | 0.066 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.596459e-01 | 0.066 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.596459e-01 | 0.066 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.596459e-01 | 0.066 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.596459e-01 | 0.066 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.596459e-01 | 0.066 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.596459e-01 | 0.066 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.596459e-01 | 0.066 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.596459e-01 | 0.066 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.650463e-01 | 0.063 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.675993e-01 | 0.062 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.677749e-01 | 0.062 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.727791e-01 | 0.059 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.727791e-01 | 0.059 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.727791e-01 | 0.059 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.727791e-01 | 0.059 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 8.727791e-01 | 0.059 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.727791e-01 | 0.059 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.727791e-01 | 0.059 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.727791e-01 | 0.059 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.747075e-01 | 0.058 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.775575e-01 | 0.057 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.775575e-01 | 0.057 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.775575e-01 | 0.057 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.806117e-01 | 0.055 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.830133e-01 | 0.054 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.846841e-01 | 0.053 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.846841e-01 | 0.053 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.846841e-01 | 0.053 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.846841e-01 | 0.053 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.846841e-01 | 0.053 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.866679e-01 | 0.052 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.920094e-01 | 0.050 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.936295e-01 | 0.049 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.936295e-01 | 0.049 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.951463e-01 | 0.048 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.954757e-01 | 0.048 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 8.954757e-01 | 0.048 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.954757e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.954757e-01 | 0.048 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.954757e-01 | 0.048 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.954757e-01 | 0.048 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.979113e-01 | 0.047 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.987215e-01 | 0.046 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.987215e-01 | 0.046 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.987215e-01 | 0.046 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.999402e-01 | 0.046 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.052579e-01 | 0.043 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.052579e-01 | 0.043 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.052579e-01 | 0.043 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.052579e-01 | 0.043 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.059182e-01 | 0.043 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.059182e-01 | 0.043 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.059182e-01 | 0.043 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.083152e-01 | 0.042 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.103590e-01 | 0.041 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.103590e-01 | 0.041 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.103590e-01 | 0.041 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.111998e-01 | 0.040 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.115773e-01 | 0.040 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.115773e-01 | 0.040 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.141252e-01 | 0.039 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.141252e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.141252e-01 | 0.039 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.141252e-01 | 0.039 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.141252e-01 | 0.039 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.179930e-01 | 0.037 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.219934e-01 | 0.035 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.221631e-01 | 0.035 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.221631e-01 | 0.035 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.221631e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.221631e-01 | 0.035 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.221631e-01 | 0.035 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.230924e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.234834e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.234834e-01 | 0.035 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.234834e-01 | 0.035 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.234834e-01 | 0.035 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.267768e-01 | 0.033 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.282822e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.294490e-01 | 0.032 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.294490e-01 | 0.032 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.294490e-01 | 0.032 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.294490e-01 | 0.032 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.294490e-01 | 0.032 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.303104e-01 | 0.031 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.303104e-01 | 0.031 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.303104e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.360533e-01 | 0.029 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.360533e-01 | 0.029 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.360533e-01 | 0.029 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.360533e-01 | 0.029 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.360533e-01 | 0.029 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.360533e-01 | 0.029 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.369481e-01 | 0.028 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.377086e-01 | 0.028 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.404075e-01 | 0.027 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.420397e-01 | 0.026 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.420397e-01 | 0.026 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.420397e-01 | 0.026 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.420397e-01 | 0.026 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.420397e-01 | 0.026 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.420397e-01 | 0.026 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.420397e-01 | 0.026 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.420397e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.444834e-01 | 0.025 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.444834e-01 | 0.025 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.474661e-01 | 0.023 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.474661e-01 | 0.023 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.474661e-01 | 0.023 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.496781e-01 | 0.022 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.503121e-01 | 0.022 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.512008e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.523847e-01 | 0.021 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.523847e-01 | 0.021 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.523847e-01 | 0.021 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.523847e-01 | 0.021 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.528020e-01 | 0.021 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.528020e-01 | 0.021 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.528020e-01 | 0.021 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.528020e-01 | 0.021 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.528020e-01 | 0.021 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.528696e-01 | 0.021 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.531695e-01 | 0.021 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.532161e-01 | 0.021 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.553960e-01 | 0.020 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.564855e-01 | 0.019 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.565007e-01 | 0.019 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.565007e-01 | 0.019 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.568430e-01 | 0.019 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.568430e-01 | 0.019 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.568430e-01 | 0.019 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.568430e-01 | 0.019 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.568430e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.592669e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.599209e-01 | 0.018 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.608842e-01 | 0.017 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.608842e-01 | 0.017 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.608842e-01 | 0.017 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.625024e-01 | 0.017 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.645471e-01 | 0.016 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.645471e-01 | 0.016 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.645471e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.660033e-01 | 0.015 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.660033e-01 | 0.015 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.660033e-01 | 0.015 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.660033e-01 | 0.015 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.667073e-01 | 0.015 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.675381e-01 | 0.014 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.688918e-01 | 0.014 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.708767e-01 | 0.013 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.708767e-01 | 0.013 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.708767e-01 | 0.013 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.712574e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.730393e-01 | 0.012 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.736044e-01 | 0.012 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.747181e-01 | 0.011 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.756126e-01 | 0.011 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.772229e-01 | 0.010 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.776456e-01 | 0.010 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.783177e-01 | 0.010 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.789524e-01 | 0.009 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.803488e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.803488e-01 | 0.009 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.803488e-01 | 0.009 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.815691e-01 | 0.008 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.821898e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.821898e-01 | 0.008 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.821898e-01 | 0.008 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.821898e-01 | 0.008 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.826426e-01 | 0.008 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.834947e-01 | 0.007 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.834947e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.838584e-01 | 0.007 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.838584e-01 | 0.007 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.852823e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.852956e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.853708e-01 | 0.006 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.853708e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.853708e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.862639e-01 | 0.006 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.867415e-01 | 0.006 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.867415e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.867415e-01 | 0.006 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.867415e-01 | 0.006 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.875824e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.879839e-01 | 0.005 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.879839e-01 | 0.005 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.885971e-01 | 0.005 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.891099e-01 | 0.005 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.901305e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.901305e-01 | 0.004 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.903896e-01 | 0.004 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.903896e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.910555e-01 | 0.004 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.911795e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.918938e-01 | 0.004 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.931873e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.933423e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.933855e-01 | 0.003 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.937747e-01 | 0.003 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.939664e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.939664e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.939664e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.939773e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.942694e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.951824e-01 | 0.002 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.952716e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.953699e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.955093e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.958934e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.958934e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.959304e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.959516e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.959523e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.965678e-01 | 0.001 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.966578e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.966578e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.969713e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.969713e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.978881e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.979933e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.984816e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.985969e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.986098e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.986227e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.987520e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.988691e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.988691e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.988981e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.990714e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.991585e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.993739e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.993739e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.994814e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.995342e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.995342e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.995374e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.995649e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.995834e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996535e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.997122e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997122e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.997155e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997545e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.997884e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998083e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998083e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998120e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.998733e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998880e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999047e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999087e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999279e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999501e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999523e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999605e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999685e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999734e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999734e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999781e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999800e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999835e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999867e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999871e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999891e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999895e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999901e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999933e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999953e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999957e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999974e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999986e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999989e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |